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Elucidating the molecular events governing the osteogenic differentiation of mouse 
embryonic stem cells (ESCs) is of extreme importance for improving the treatment of 
bone-related diseases. Osteoblast differentiation is a key step in proper skeletal 
development and acquisition of bone mass; however, the physiological role of non-
coding small RNAs, especially microRNAs (miRNAs), in osteoblast differentiation 
remains elusive.  
In this study miRNA profiling was used to identify miRNAs that are potentially involved in 
osteogenesis. In addition, functional characterization and target identification of these 
miRNAs were performed to further unravel the molecular mechanisms underlying 
osteogenesis. Among the more than 250 miRNAs examined, twenty-five miRNAs in 
particular were significantly expressed during osteogenic differentiation. Eleven miRNAs, 
namely miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, miR-293, miR-300, miR-
361, miR-467b, miR-665 and miR-690, were identified to be differentially expressed in 
undifferentiated ESCs versus ESCs differentiated into osteoblasts. Overexpressing and 
knocking down these miRNAs caused changes in cell survival, cell morphology, and 
osteogenic differentiation capacity as measured with calcium deposition, ALP activity 
and expression of osteogenic markers. Using three different miRNA target identification 
approaches, most targets were found to be associated with the Wnt signaling pathway. 
We conclude from this study that as the Wnt pathway has been shown to be one of the 
major pathways involved in osteogenic differentiation of ESCs, the current results 
suggest a role for the identified miRNAs in this process.  
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Summary VI 
Summary 
Skeletal development requires stringent control of programs for gene activation and 
suppression in response to physiological cues. There has been a principal focus on 
the identification of the mechanisms by which a particular cell phenotype is activated. 
MicroRNAs (miRNAs, miRs) have emerged as key negative regulators of diverse 
biological and pathological processes, including developmental timing, 
organogenesis, apoptosis, cell proliferation and differentiation; how they regulate 
osteoblast specific gene expression, is poorly understood. miRNAs are small 22 
nucleotides (nt) endogenous non-coding RNAs (ncRNAs) that anneal to 3’ 
untranslated region (3’UTR) of target messenger RNA (mRNA) to mediate inhibition 
of translation and lower protein level. It remains to be established how specific 
miRNAs contribute to regulate the onset of a tissue-specific phenotype. 
One previously identified important player in the activation of skeletal-related genes 
that control formation of bone tissue is Wnt (wingless) signaling. The Wnts are 
regulating the differentiation of multiple cell types but also are driving embryonic stem 
cells (ESCs) into specific lineages, for example they support osteoblastogenesis. By 
attaching to the membrane, Wnts direct a signaling cascade for accumulation of β-
catenin (CatnB), which in turn activates osteoblast-essential genes. The contribution 
of global mechanisms is equally important for understanding tissue development and 
diseases. 
The aim of this study was to identify miRNAs that are differentially expressed in 
osteogenically differentiated ESCs. In addition, functional characterization of these 
miRNAs was performed to further unravel the molecular mechanisms underlying 
osteogenesis. Finally, an important goal was to identify the mRNA targets of these 
miRNAs, which are required for differentiation of ESCs into osteoblasts with a 
primary focus on mRNAs associated with the Wnt signaling pathway.  
 
miRNA expression profiling reveals an overall down-regulation of miRNAs 
during osteogenic differentiation of ESCs 
To identify miRNAs that are potentially involved in osteogenesis ESCs were 
differentiated into osteoblasts and compared to undifferentiated ESCs using a miRNA 
microarray. miRNA profiling during the initial stages of osteoblast differentiation 
showed 25 miRNAs significantly differentially expressed. Differential expression of 4 
miRNAs tested was confirmed using quantitative real-time PCR (RT-qPCR). Many 
Summary VII 
miRNAs were expressed at low levels in differentiated ESCs. Indeed, down-
regulation of miRNAs appeared to be common during differentiation. Furthermore, 
related miRNAs encoded on the same chromosome showed similar expression 
profiles. In summary, though several miRNAs were identified that can significantly 
distinguish between undifferentiated and osteogenically differentiated ESCs, 11 were 
chosen for further functional analysis. 
 
Functional studies show that miR-127, miR-183, miR-291b-5p, miR-293, miR-
361, miR-467b and miR-665 affect osteogenesis of ESCs 
Undifferentiated and differentiated ESCs were used for functional studies of 11 
miRNAs (miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, miR-293, miR-300, 
miR-361, miR-467b, miR-665 and miR-690), which were down-regulated during 
osteogenic differentiation. To asses the function of these miRNAs, gain- and loss-of-
function experiments were performed. Overexpressing and knocking down these 
miRNAs caused changes in cell survival, cell morphology, and osteogenic 
differentiation capacity as measured with calcium deposition, ALP activity and 
expression of osteogenic markers. Particularly, overexpression of miR-361 and 
knockdown of miR-665 significantly enhanced mineralization and expression levels of 
osteogenic markers. Thus, both miRNAs might regulate osteogenic differentiation in 
the early stages of lineage specification and commitment. 
 
miRNAs are modulators of osteogenic differentiation 
To identify miRNA target candidates that may account for the observed effects on cell 
survival and osteogenic differentiation of ESCs, a combined approach of 
bioinformatic predictions, mRNA expression analysis, and TurboGFP reduction upon 
miRNA overexpression coupled with the search of known literature was performed to 
identify cellular events that the identified miRNAs might be involved in.   
Target identification suggested that the candidate miRNAs may interfere with the Wnt 
pathway as many target candidates were detected that were known to be Wnt 
signaling-associated. To confirm that miR-183, miR-293, miR-361, miR-665 and miR-
690 regulated osteoblast differentiation, target mRNA/miRNA interaction was studied 
using RT-qPCR. Overexpression of these miRNAs reduced the levels of the key 
factors involved in Wnt signaling; particularly Wnt inhibitor factor 1 (WIF-1) levels 
were decreased by miR-293, nuclear factor of activated T cells 3 (NFATc-3) and 
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Prickle-1 by miR-361, Dishevelled 1 (Dvl-1) by miR-665 and for forkhead box O 3 
(FoxO-3), Ras homolog gene family, member A (RhoA) and CatnB-1 by miR-690.   
Thus, to address the hypothesis that miR-361 activates osteoblast differentiation by 
targeting Prickle-1 and NFATc-3, the p2FP-RNAi vector system was applied. It was 
shown that expression of miR-361 down-regulates Prickle-1 levels, which to our 
knowledge have not been described so far. As it was found previously, Prickle-1 
reduced Dvl-3 levels by promoting its ubiquitination, resulting in inhibition of Wnt 
canonical signaling in liver cancer. Since Dvls are positive regulators of osteogenesis 
by elevating CatnB levels and stimulating lymphoid enhancer factor/T cell factor 
proteins (LEF/TCF) -dependent transcription in the canonical Wnt pathway, Prickle-1 
might be a negative regulator of osteogenic differentiation by eliminating Dvls from 
the complex. This interaction offers a novel mechanism of Wnt signaling activation in 
osteogenesis and can be explored to identify key components in the Wnt signaling 
pathway. 
In summary, we suggested that miR-361 acts as an activator in osteogenic 
differentiation of ESCs. 
 
Zusammenfassung IX 
Zusammenfassung 
Die Embryonalentwicklung des Skelettsystems ist in Bezug auf programmierte 
Genaktivierung in Antwort auf physiologische Schlüsselreize strikten Kontrollen 
unterworfen. Studien zur Untersuchung solcher Kontrollelemente haben sich dabei 
vor allem auf die Identifikation von Mechanismen fokussiert, die einen bestimmten 
zellulären Phänotyp aktivieren. Zum Vorschein kamen microRNAs (miRNAs), die als 
negative Schlüsselregulatoren diverser biologischer und pathologischer Prozesse 
wirken, wie zum Beispiel der zeitlichen Regulation von Entwicklung, der 
Organogenese, Apoptose, zellulärer Proliferation und Differenzierung. Wie sie 
allerdings die Osteogenese, den Prozess der Knochenbildung, regulieren ist 
weitestgehend unbekannt. 
MiRNAs sind kurze 22 Nukleotid lange endogene nicht-kodierende RNAs (ncRNAs), 
die an die 3' nicht translatierte Region (3'UTR) einer Ziel mRNA binden und somit die 
Inhibition der Translation vermitteln, was letzten Endes zu einer Erniedrigung des 
Proteinlevels führt. Es bleibt allerdings zu etablieren, wie spezifische miRNAs zur 
Spezifikation in einen bestimmten Zell- oder Gewebephänotyps beitragen. 
Einer der bisher identifizierten Akteure, der die Aktivierung von skelettalen Genen 
kontrolliert, ist der Wnt (wingless) Signalweg. Wnt Moleküle regulieren die 
Differenzierung vieler unterschiedlicher Zelltypen, aber lenken auch die 
Differenzierung von embryonalen Stammzellen (ESCs) in spezifische Richtungen, so 
z.B. in die Richtung von Knochenzellen, den Osteoblasten. Indem sie an die 
Zellmembran andocken, dirigieren Wnts eine Signalkaskade, die die Akkumulation 
von beta-catenin (CatnB) im Zellkern nach sich zieht, wodurch knochenspezifische 
Gene aktiviert werden. Obwohl die Wnt Signalkaskade weitestgehend beschrieben 
ist, ist der Beitrag globalerer Regulationsmechanismen, wie die der miRNAs, an der 
Osteogenese jedoch gleichfalls für das Verständnis von Gewebeentwicklung und -
fehlfunktion von Bedeutung.  
Das Ziel dieser Arbeit war es deshalb bestimmte miRNAs zu identifizieren, die 
differentiell in ESCs exprimiert werden, die zu Knochenzellen ausdifferenzieren. 
Desweiteren sollten diese miRNAs funktionell charakterisiert werden, um die 
molekularen Mechanismen, die der Osteogenese unterliegen, aufzudecken. 
Letztendlich war es ein weiteres wichtiges Ziel die Ziel mRNAs der 
knochenspezifischen miRNAs zu identifizieren und deren Bezug zum Wnt Signalweg 
zu charakterisieren.  
Zusammenfassung X 
miRNA Expression ist während der osteogenen Differenzierung herunter 
reguliert 
Um solche miRNAs zu identifizieren, die potentiell in die Osteogenese eingreifen, 
wurden ESCs zu Osteoblasten differenziert und mit undifferenzierten ESCs mit Hilfe 
eines miRNA Microarrays verglichen. Das so durchgeführte miRNA Profiling zeigte, 
dass 25 miRNAs während der initialen Phase der osteogenen Differenzierung 
signifikant unterschiedlich exprimiert wurden. Die differentielle Expression von 4 
getesteten miRNAs wurde in einem nächsten Schritt über quantitative real-time PCR 
(RT-qPCR) beispielhaft bestätigt. Generell zeigte sich, dass differenzierende ESCs 
viele miRNAs auf geringem Niveau exprimieren. Tatsächlich schien die 
Herunterregulation der miRNA Expression mit der Differenzierung der Zellen 
einherzugehen. Desweiteren zeigten miRNAs, die auf dem gleichen Chromosom 
kodiert sind, ähnliche Expressionsmuster. Zusammenfassend fanden sich etliche 
miRNAs, die in undifferenzierten Zellen im Vergleich zu differenzierenden Zellen 
unterschiedlich exprimiert werden, von denen schlussendlich 11 für weitere Analysen 
ausgewählt wurden (miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, miR-293, 
miR-300, miR-361, miR-467b, miR-665 and miR-690). 
 
miR-127, miR-183, miR-291b-5p, miR-293, miR-361, miR-467b und miR-665 
beeinflussen die Osteogenese  
In einem nächsten Schritt wurden undifferenzierte und differenzierende ESCs für 
funktionelle Studien dieser 11 herrunterregulierten miRNAs herangezogen. Um die 
Funktion dieser miRNAs aufzudecken, wurden sogenannte Gain-of-function und 
Loss-of-function Studien durchgeführt. Die experimentelle Überexpression und der 
Knock-down dieser miRNAs führten zu Änderungen in der zellulären Morphologie, 
der Viabilität und der osteogenen Differenzierungskapazität wie durch einen 
Kalziumdepositionsassay, einen ALP Aktivitätsassay und die Expression 
knochenspezifischer Markergene gezeigt werden konnte. Im Besonderen erhöhte die 
Überexpression der miR-361 und der Knock-down der miR-665 den 
Mineralisierungsgrad der Zellen und die Expressionniveaus knochenspezifischer 
Gene. Daher ist zu schließen, dass beide miRNAs das Potential besitzen, die 
Osteogenese - besonders in den frühen Stadien der Keimbahnspezifikation - zu 
regulieren. 
 
Zusammenfassung XI 
miRNAs als Modulatoren der Osteogenese 
Um miRNA Zielkandidaten zu identifizieren, die die beobachteten Effekte auf die 
Zellviabilität und auf die osteogene Differenzierungen bedingen könnten, wurde ein 
kombinierter Ansatz aus Bioinformatischer Sequenz- und Prädiktionsanalyse, mRNA 
Expressionsanalyse und TurboGFP Reduktion nach miRNA Überexpression gewählt. 
Gepaart mit einer Literatursuche deutete diese Zielkandidatenanalyse darauf hin, 
dass die identifizierten miRNAs tatsächlich den Aktivierungsstatus des Wnt 
Signalwegs manipulieren könnten, da viele der prädiktierten Target mRNAs bekannt 
dafür sind, mit dem Wnt Signalweg zu interagieren. 
Um zu bestätigen, dass miR-183, miR-293, miR-361, miR-665 und miR-690 die 
Osteogenese regulieren, wurde die mRNA/miRNA Interaktion indirekt mittels RT-
qPCR studiert. Die Überexpression dieser miRNAs führte zu einer Erniedrigung des 
mRNA Expressionsspiegels von WIF-1 (Wnt inhibitory factor 1) durch miR-293, 
NFATc-3 (nuclear factor of activated T cells 3) und Prickle-1 durch miR-361, 
Dishevelled 1 (Dvl-1) durch miR-665, sowie forkhead box O3 (FoxO-3), Ras homolog 
gene family, member A (RhoA) und CatnB durch miR-690. 
In einem nächsten Schritt konnte durch Nutzung eines speziellen Reportersystems 
(TurboGFP) eine direkte Interaktion zwischen miR-361 und Prickle-1 nachgewiesen 
werden. Wie bereits in anderen Studien gezeigt, ist Prickle-1 in der Lage, die Spiegel 
an Dvl-3 durch Ubiquitinierung des Proteins zu reduzieren, was zur Inhibierung des 
kanonischen Wnt Signalweges führt. Da Dvls als positive Regulatoren der 
Osteogenese bekannt sind, indem sie den CatnB Spiegel erhöhen und die lymphoid 
enhancer factor/T cell factor protein (LEF/TCF) abhängige Transkription stimulieren, 
könnte Prickle-1 als negativer Regulator fungieren, indem es Dvls von diesem 
Transkriptionskomplex entfernt.  
Abschließend lässt sich zusammenfassen, dass miR-361 in dieser Arbeit als 
neuartiger Aktivator der osteogenen Differenzierung vorgeschlagen wird. Die 
molekulare Interaktion zwischen miR-361, Prickle-1 und Dvls bietet einen neuartigen 
Mechanismus der Wnt Signalaktivierung während der Osteogenese und kann für 
weitere Untersuchungen zur Identifizierung von Schlüsselkomponenten des Wnt 
Signalweges herangezogen werden. 
 
1 Introduction 1 
1 Introduction 
MicroRNAs (miRNAs, miRs), as regulatory RNAs, play important roles in cellular 
processes including proliferation, differentiation, apoptosis, survival, motility and 
morphogenesis as well as in bone formation and bone remodeling (Callis et al., 
2007). miRNA expression patterns may become powerful biomarkers for diagnostic 
approaches and miRNA therapy could be a novel strategy for the treatment of 
degenerative bone disorders. Stem cells are an ideal model to study vertebrate 
differentiation and development. These cells are also found in various tissues 
throughout the entire body. They reside in niches within tissues and are specified by 
the highly specialized niche cells that regulate their pluripotency and differentiation. 
Such cells are not only found in the adult body, but also during early development. 
Indeed, stem cells can be a useful in cell replacement therapy. 
 
1.1 Stem cells 
Stem cells are functionally defined as cells with the unique capacity to differentiate 
into other cell types of the organism. In addition, they possess the ability to self renew 
(Nakahata and Ogawa 1982; Mountford et al., 2008). Developmental potency is 
another functional characterization of stem cells and does not necessarily describe 
the range of genes expressed by the cells or their origin (Niwa et al., 2000).  
Different types of stem cells exist, depending on the ability to maintain stem cell-like 
properties and the variability of derivatives that they give rise to. Totipotent  stem 
cells are produced from the fusion of an egg and a sperm and by the first few 
divisions of the fertilized egg. These cells can differentiate into embryonic and 
extraembryonic cell types. Pluripotent stem cells are the descendants of totipotent 
cells. The hallmark of pluripotent stem cells is the potential to give rise to the 
representatives of the three germ layers: endoderm, mesoderm and ectoderm. Three 
types of pluripotent stem cells have been described so far: i) embryonic germ cells of 
the gonad and a post implantation embryo (Denham et al., 2005), ii) embryonal 
carcinoma cells, originating from tumorigenic germinal tissue (Denham et al., 2005) 
and iii) embryonic stem cells (ESCs) (Denham et al., 2005). Multipotent stem cells 
can produce two or more differentiated cell types particularly only cells of a closely 
related family. For example, hematopoietic stem cells, the resident cells of bone 
marrow, give rise to lineage restricted stem cells, which can further differentiate into 
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numerous blood cell types (Kondo et al., 2003).  Unipotent stem cells can produce 
only one cell type, but have the property of self-renewal which distinguishes them 
from non-stem cells. Recently, new pluripotent cell lines were induced through a 
process of reprogramming somatic cells and were named induced pluripotent stem 
cells (iPSCs) (Takahashi and Yamanaka 2006; Takahashi et al., 2007).  
The potency of pluripotent stem cells may be revealed experimentally in vitro by i) 
forming aggregates in suspension culture by ii) forming a teratoma following infection 
into immunocompromised mice in vivo and by iii) giving rise to an embryo after 
injection into the blastocyst and resulting in the birth of chimeras (Nagy et al., 1993; 
Wang et al., 1997). Embryoid body (EB) culture is mostly used to examine the 
differentiation potential of the ESC line. There are several techniques to encourage 
EB formation include the suspended drop method, the bacteriological culture Petri 
dish method and using semisolid substrates, such as methylcellulose. 
 
1.2 Derivation of murine ESCs   
ESCs are derived from early-stage embryos and posses the ability to self-renew 
under certain the in vitro conditions while maintaining the potential to differentiate into 
the three primary  lineages and germ cells (Aflatoonian et al., 2006). ESCs were first 
derived from the inner cell mass (ICM) of mouse blastocysts in 1981 by Martin Evans 
and Matthew Kaufman (Evans & Kaufman, 1981). During the same year Gail R. 
Martin also derived ESCs from mouse embryos, independent of Evans and Kaufman, 
and coined the term “embryonic stem cells” to distinguish these embryo-derived 
pluripotent cells from teratocarcinoma-derived pluripotent embryonal carcinoma cells 
(Martin, 1981; Andrews et al., 2005). Interestingly, the efficiency in deriving ESCs is 
strongly affected by the genetic background. Study on different mouse strains have 
demonstrated that mouse ESCs can be easily derived from inbred mouse strains 
particularly 129/ter SV, while deriving ESCs from other strains may be less efficient 
(Ledermann et al., 1991). These cells can be expanded indefinitely in vitro to give 
relative homogenous and undifferentiated ESC population (Smith et al., 2001). 
Murine ESCs exhibit remarkable features in culture, firstly under the appropriate 
conditions they can be propagated indefinitely as a stable self-renewing population 
where at every cell division, both mother and daughter cell, retain stem-cell identity 
following a symmetric cell division (Zwaka et al., 2005). Secondly, a feature of more 
developmental relevance is that during extended culture, ESCs retain their 
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pluripotency and can differentiate into the same range of cell types as those formed 
in the embryo from the ICM. Pluripotency can only be maintained when co-cultured 
with a feeder layer made from mouse embryonic fibroblasts (Martin et al., 1981). It 
was reasoned that some extrinsic factor must exist to both suppress differentiation 
and promote self-renewal. This factor was identified to be leukemia inhibitory factor 
(LIF) (Williams et al., 1988), and the LIF/signal transducer and activator of 
transcription 3 (STAT-3) signaling pathway has been established to play a central 
role in maintaining mouse ESC pluripotency (Niwa et al., 1998).  
 
                        
 
Figure 1. The origin, isolation and specialization of stem cells. Zygote and early cell division 
stages to the morula stage are defined as totipotent. At the blastocyst stage, only the cells of the inner 
cell mass and the embryonic stem cells retain the capacity to build up all three primary germ layers, as 
well as the primordial germ cells, and are pluripotent. Stem cells in the fetal tissues exist during fetal 
development and some stem cells are retained until adult age. In adult tissues, multipotent stem and 
progenitor cells exist in tissues and organs to replace lost or injured cells (Chaudry A, 2004). 
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1.2.1 Maintaining undifferentiated murine ESCs 
Undifferentiated mouse ESC possesses a distinct morphology. The individual cell 
contains a large nucleus and a cytoplasm of relatively small ratio. Under the 
microscope cells also appear as a tightly packed 3 dimensional formed colony with a 
defined border at the periphery. The long term proliferation capacity of mouse ESCs 
is an important issue and a specialized growth environment is required to retain the 
undifferentiated phenotype. Several signal pathways are involved in maintaining 
pluripotency of mouse ESCs (Zandstra et al., 2000; Niwa et al., 2001; Oka et al., 
2002). One of the best characterized is the LIF/STAT-3 cascade. As a member of the 
interleukin 6 (IL-6) cytokine family, LIF plays a key role by engaging the LIFR/gp130 
receptor, thereby recruiting and activating STAT-3, a transcription factor that 
regulates gene expression required for stemness (Starr et al., 1997; Smith et al., 
2001; Viswanathan et al., 2002). A number of steps involving two main signaling 
molecules called JAKs (Janus kinases), which are non-receptor cytoplasmic protein 
tyrosine kinases, and STATs are activated as a result of this heterodimerization 
reaction (Fukada et al., 1996; Niwa et al., 1998; Burdon et al., 1999; Matsuda et al., 
1999). A current study provided evidence that LIF maintains a proliferative, self-
renewing state in mouse ESCs in a synergistic manner with Wnt ligands (Ogawa et 
al., 2006). This finding suggests that LIF may not be sufficient for maintaining 
pluripotency long term alone. Genetic inactivation of LIF signaling has no major effect 
on embryonic development although LIF/STAT-3 seems to be important for survival 
of the blastocyst during delayed implantation (Nichols et al., 2001).  
A second pathway implicated in mouse ESC self-renewal involves bone 
morphogenetic protein (BMP) signaling. Although BMP is generally not added as a 
recombinant factor, as in the case for LIF, the BMPs found in fetal calf serum (FCS) 
appear to have a maintenance effect at least under some culture conditions (Ying et 
al., 2003; Qi et al., 2004). BMP acts by promoting DNA-binding protein inhibitor (Id) 
gene expression, which serves to block neural differentiation (Ying et al., 2003). An 
alternative explanation on how BMP impacts mouse ESC self-renewal could be found 
in the fact that BMP blocks differentiation by suppressing the P38 mitogen-activated 
protein kinase (p38MAPK) (Kunath et al., 2007). Furthermore, the Wnt pathway plays 
a crucial role in self-renewal of mouse ESCs. Signaling downstream of the 
Wnt/Frizzled (Fzd) receptor leads to the inactivation of glycogen synthase kinase-3β 
(GSK-3), regulating the accumulation of β-catenin (CatnB) in the nucleus, which in 
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turn activates the transcription of target genes. Activation of Wnt signaling by a 
specific pharmacological GSK-3 inhibitor 6-bromoindirubin-3’-oxime (BIO) has been 
reported to have a positive effect on mouse ESC self-renewal, as detected by 
expression of pluripotency markers such as octomer binding protein 4 (Oct-4) and 
Nanog (Sato et al., 2004). 
 
1.2.2 Markers of mouse ESCs and the transcriptional network in ESCs 
The undifferentiated mouse ESCs express multiple transcription factors associated 
with pluripotency and self-renewal including Oct-4 (Niwa et al., 2000), Nanog (Mitsui 
et al., 2003; Chambers et al., 2003) and SRY-related HMG box 2 (Sox-2) (Yuan et 
al., 1995; Avilion et al., 2003). Furthermore, mouse ESCs retain alkaline phosphatase 
(ALP) activity and a high telomerase activity, which indicates an unlimited 
proliferative capacity. In addition, they express surface markers, such as stage-
specific embryonic antigen 1 (SSEA-1), which is down-regulated upon differentiation. 
Establishment of the pluripotent state of ESCs is an important issue in stem cell 
biology and regenerative medicine. Oct-4 (also known as Oct-3 and encoded by 
Pou5f1) is a POU domain-containing transcription factor that binds to an octamer 
sequence, ATGCAAAT. During mouse pre-implantation development, Oct-4 
expression is activated at the four-cell stage and is later restricted to the ICM and 
germ cells. Loss of Oct-4 causes inappropriate differentiation of ESCs into 
trophectoderm, whereas overexpression of Oct-4 results in differentiation into 
primitive endoderm and mesoderm (Yeom et al., 1996; Niwa et al., 2001). Oct-4 
activity is modulated by interactions with other transcription factors that include Sox-
2, forkhead box D3 (FoxD-3), and embryonal stem cell-specific gene 1 (ESG-1), 
which are highly expressed in ESCs. Sox-2 forms a complex with the Oct-4 protein 
regulating downstream genes together. Nanog is one of the Oct-4/Sox-2 complex 
targets and is needed to maintain pluripotency, but it is not necessary for induced 
pluripotency following somatic cell reprogramming (Jaenisch et al., 2008). The 
mechanism whereby Nanog regulates stem cell pluripotency remains unclear. It has 
been proposed that Nanog represses the downstream genes that are important for 
endodermal differentiation, such as GATA-4 and GATA-6 (Chen et al., 2006). 
Moreover, Nanog can activate others genes that are important for self-renewal, such 
as Rex-1, which is a target gene of the Oct-4/Sox-2 complex and it is also suggested 
that Rex-1 can be an intersection of Nanog and Oct-4/Sox-2 signaling (Shi et al., 
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2006). One of the currently discovered elements of the regulatory network that 
maintain self-renewal and pluripotency is the RE-1 silencing transcription factor 
(REST) (Singh et al., 2008). It has been reported that decreased REST levels lead to 
a loss of Oct-4 and Nanog expression and increase levels of lineage-specific 
differentiation markers. Furthermore, a reduction of REST protein in mouse ESCs 
leads to activation of specific miRNAs, such as miR-21, and this subsequently results 
in loss of pluripotency (Singh et al., 2008).  
 
1.2.3 Differentiation of mouse ESCs and methods to promote differentiation 
Development of EBs by the aggregation of ESCs in suspension or hanging 
drops leads to the generation of cell populations, which express genes indicative of 
lineages from all three germ layers. Studies of mouse development have identified 
several secreted factors, which mediate critical events in cellular commitment and 
development. The mouse ESC differentiation in vitro reveals evidence for a role for 
BMP-2 in the formation of extra embryonic endoderm and in the gastrulation of the 
embryo (Coucouvanis et al., 1999).  Culture of ESCs in vitro has shown that they 
respond to signals operated in the early embryo and give rise to cell lineages 
resembling the situation in vivo. For specific lineage differentiation, undifferentiated 
ESCs can be induced to enter a program of differentiation by removal of LIF, feeder-
cell layer and subsequent transfer into suspension culture (Itskovitz-Eldor et al., 
2000). The technique used most widely to differentiate ESCs is to culture them in 
liquid or methyl cellulose containing media in bacterial grade Petri dishes. Under 
these conditions, the ESCs are unable to adhere to the surface of the culture dish, 
and spontaneously aggregate to form EBs. EBs can also be induced to form by 
culturing ESCs in ‘hanging drops’ for several days. The close association of the 
ESCs in these cultures promotes the efficient generation of EBs. Once formed, EBs 
can be transferred to standard liquid cultures to complete their development. 
Exposure to selected growth factors or their antagonists is a useful strategy for 
directing the differentiation of ESCs. For instance, evaluation of the effects of several 
growth factors on pre-differentiated mouse ESCs demonstrated that transforming 
growth factor β (TGFβ), Activin A and BMP-4 mainly induced mesodermal 
differentiation (Winnier et al., 1995; Kimelman et al., 2006), but BMP-4 as wells as 
retinoic acid (RA) can also stimulate ectodermal differentiation (Rohwedel et al., 
1999; Rodda et al., 2002). 
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1.3 Bone tissue differentiation 
Bone tissue is a specialized form of connective tissue, which is present in the 
skeleton. The skeleton, composed of cartilage and bone, is essential for providing a 
scaffold for soft tissue, but also serves as a reservoir for calcium, magnesium and 
phosphate ions. The composition of bone includes two main cell populations 
(osteoblast and osteoclast lineages) and an extracellular matrix-associated organic 
and mineral phase, composed of non-collagen proteins, such as fibronectin, and 
growth factors, collagen types I and III (Col I & III) and hydroxyapatite crystals, 
respectively (Hill, 1998). 
Throughout embryogenesis, bone tissue is formed by two processes: 
intramembraneous ossification, during which clusters of cells adhere trough the 
expression of adhesion molecules and differentiate into osteoblasts (Karasenty et al., 
2000) and endochondral ossification, during which cells migrate to the regions of the 
embryo where they form chondrocystic mesenchymal condensations of high cell 
density. Bone-producing cells, the osteoblasts, originate from mesenchymal cells and 
are responsible for the production of extracellular matrix, which is mainly composed 
of Col I. Active osteoblasts are cuboidal and are nearly indistinguishable from 
fibroblasts in cell culture. All genes expressed in fibroblasts are also expressed in 
osteoblasts (Ducy et al., 2000). Osteoblast deposit, osteoid, which is unmineralized 
extracellular matrix (ECM), subsequently becomes calcified. During this process cells 
are trapped within the lacunae of the matrix and are termed osteocytes.  One of their 
proposed functions is to regulate the response of bone to mechanical stimuli, which is 
only possible because osteocytes are connected to each other by a canaliculi system 
(Ehrich et al., 2002). Osteoblasts are also involved in the differentiation of bone 
resorbing cells, the osteoclasts, which are derived from the monocyte/macrophage 
hematopoietic lineage. Activation of receptor activator of nuclear factor κ B-cells 
(RANK) by the osteoblast expressed RANK ligand (RANKL) and macrophage colony-
stimulating factor (M-CSF) commit cells to the osteoclast fate (Horowitz et al., 1989). 
 
1.3.1 Osteoblast differentiation form murine ESCs  
A population of cells that is committed to acquire an osteoblastic phenotype is called 
osteoprogenitors. Proliferation and differentiation of osteoprogenitor cells is controlled 
by the expression of bone specific genes. Three chronologically related stages can 
be defined during osteogenic differentiation: i) a proliferative phase, ii) an ECM 
1 Introduction 8 
deposition, maturation and expression of ALP phase, and iii) a mineralization phase 
(zur Nieden et al., 2003). Col I, osteonectin (ON) and ALP are expressed at high 
levels near the end of proliferative state and during the beginning of matrix 
deposition. At the end of the second and at the beginning of a mineralization phase 
osteopontin (OPN) mRNA is expressed and the process of calcium phosphate apatite 
deposition is also started. Calcification is coordinated by several ECM proteins 
including bone sialoprotein (BSP). Finally, the level of osteocalcin (OCN) mRNA is 
enhanced.  
In vitro differentiation of murine ESCs into osteoblasts is triggered by the addition of 
certain factors, such as ascorbic acid (AA), 1α,25-OH2 vitamin D3 (VD3) and β-
glycerophosphate (βGP) (zur Nieden et al., 2003), which in vivo are released by cells 
from the microenvironment of osteoblasts (Duplomb et al., 2007a). Several studies 
have investigated the osteogenic differentiation potential of ESCs. The first study was 
based on mouse ESCs; their  differentiation  toward the osteoblast lineage was 
enhanced by supplementing serum-containing media with AA, βGP and/or 
dexamethasone (Dex)/RA or by co-culture with fetal murine osteoblasts (Buttery et 
al., 2001). ESCs differentiation into osteoblasts was characterized by the formation of 
discrete mineralized bone nodules within an ECM composed of Col I and OCN. Dex 
in combination with AA and βGP induced the greatest number of bone nodules and 
was dependent on time of stimulation (Buttery et al., 2001).  
One of the initial strategies to derive differentiated tissue from mouse ESCs was the 
formation of EBs (Philips et al., 2001; zur Nieden et al., 2003; Bourne et al., 2004). 
Two methods have been used for EB formation, the hanging drop method and 
suspension culture on non-adherent plates. The addition of supplements, such as 
AA, βGP, Dex and VD3 resulted in the increased differentiation along the osteogenic 
pathway. Besides the traditional osteogenic supplements, RA treatment during the 
EB phase has been used. Indeed, it was demonstrated that RA increased the 
number of mineralized nodules (Philips et al., 2001). More recently a study aimed at 
defining some key factors that drive mouse ESCs into specialized mesenchymal 
fates. The approach was based on RA treatment, followed by BMP and TGFβ-3 
exposure (Kawaguchi et al., 2005). It has been shown that Dex, βGP and AA were 
necessary for calcium deposition in EB outgrowth. Moreover, the differentiation of 
osteoblasts from mouse ESCs without the generation of EBs was lately reported 
(Duplomb et al., 2007b). Microarray studies on mouse ESCs which had been 
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stimulated with serum-containing medium supplemented by AA, Dex and βGP 
revealed a combination of up-regulated genes in osteoblast differentiation, such as 
OPN and insulin growth factor 2 (IGF-2) and a down-regulation of genes, which are 
involved in neuroectoderm differentiation (Bourne et al, 2004). Taken together, all 
these models still lack defined conditions for the differentiation and isolation of pure 
osteogenic precursor populations. 
 
1.3.2 Transcriptional control of osteoblast differentiation 
Early development of the vertebrate skeleton depends on genes that pattern the 
distribution and proliferation of cells from the cranial neural crest, sclerotomes, and 
lateral plate mesoderm into mesenchymal condensations at sites of future skeletal 
elements. What is currently known about the molecular and cellular basis of skeletal 
development is largely the result of experimental animal studies and investigations of 
bone disorders. Runt-related factor 2 (Runx-2) also known as core-binding factor α1 
(Cbfα-1), is a central mediator that executes signals from the BMP and Wnt pathways 
to promote cell phenotype commitment and osteogenic differentiation. Runx-2 is a 
member of the Runx family of transcription factors and operates in bone lineage cells 
by binding to the Runx consensus sequence (PuACCPuCA). The Runx regulatory 
element can be found in the promoter of all major osteoblast genes controlling their 
expression, including the Col I α1 chain, OPN, BSP and OCN, resulting in the 
establishment of an osteoblast phenotype (Komori, 2008; Franceschi et al., 
2007). Molecular studies and genetic manipulation of Runx-2 in vivo indicated that 
the expression of Runx-2 is both necessary and sufficient for mesenchymal cell 
differentiation towards the osteoblast lineage (Karsenty et al., 2002; Komori et al., 
2006). Runx-2 is auto-regulated with seven Runx-2 responsive sites throughout the 
promoter and additionally can be phosphorylated and activated by the mitogen-
activated protein kinase (MAPK) pathway by binding Col I to α2β1 integrins on the 
osteoblast surface (Komori, 2000). Disruption of Runx-2 results in the complete lack 
of bone tissue, revealing that Runx-2 is essential for bone formation (Komori et al., 
1997).  
The other important player in osteoblast differentiation is osterix (Osx), a zinc finger 
transcription factor. Osx and NFATc form a complex, resulting in the activation of the 
Wnt signaling pathway and bone formation (Winslow et al., 2006). The regulation of 
Osx expression is poorly known; however it was found that Schnurri 2 and p53 
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repress Osx transcription and thereby down-regulate osteoblastogenesis (Saita et al., 
2007; Zambetti et al., 2006).  
Canonical Wnt signaling is a third major pathway, which controls bone formation and 
bone mass (Day et al., 2005; Hill et al., 2005; Hu et al., 2005). Wnt signaling is 
activated by the formation of the complex with the membrane bound receptor Fzd 
and low density lipoprotein receptor related protein 5/6 (LRP-5/6) in the cell surface. 
The following transduction occurs through the protein Dishevelled (Dvl), which 
inhibits a protein complex of axin/adenomotous polyposis coli (APC)/GSK-3. In the 
absence of a suitable ligand, CatnB, the key effector of this pathway, becomes 
phosphorylated and is degenerated. Free cytosolic CatnB is then translocated to the 
nucleus where it binds to lymphoid enhancer factor/T cell factor (LEF/TCF) 
transcription factors and activates downstream genes, such as Runx-2 (Gaur et al., 
2005).  
 
1.3.3 Regulation of osteoblast differentiation 
A number of growth factors have been identified to be important for the local control 
of osteogenic differentiation. As mentioned above, the Wnt canonical pathway 
appears to be the important for bone biology (Westendorf et al., 2004). Although it is 
known that pathologically high levels of Wnt signaling result in higher bone density, 
however the exact function of Wnt in bone biology remains unclear (Glass et al., 
2006). Mice deficient for the Wnt receptor LRP-5/6 were viable, but postnatally 
developed a low bone mass phenotype because of reduced osteoblast proliferation 
and function (Kato et al., 2002). Furthermore, in the absence of CatnB, 
osteoprogenitors failed to express Osx and instead differentiate into chondrocytes 
(Hill et al., 2005). Thus, CatnB seems to be required for osteoblast differentiation at a 
very early stage.  
TGFβ-1 also regulates osteoblast proliferation and matrix synthesis including 
mineralization and stimulates bone formation through regulation of Runx-2 
expression (Oreffo et al., 1989). However, TGFβ-1 cannot initiate the bone formation 
cascade like the BMPs (Rose et al., 2004). BMPs were originally identified as 
proteins present in demineralized bone matrix that could induce osteogenesis 
(Wozney et al., 1988). The BMPs are found in the bone matrix and are synthesized 
by skeletal and extraskeletal tissues as larger precursor molecules, which are 
processed to around 30 kDa dimers before their secretion to the cell (Sakou et al., 
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1998).  Both TGFβ-1 and BMPs exert their signaling effects via BMP receptors type I 
and II and Sma and Mad related proteins 1, 5 and 8 (SMAD-1/5/8) molecules. 
SMADs become phosphorylated by BMP and are transported to the nucleus in a 
complex with SMAD-4, where they regulate their target genes Runx-2 and Osx 
(Wantanabe et al., 1999; Zhang et al., 2000; Nakashima et al., 2002). 
The mineralized bone matrix also contains fibroblast growth factors (FGFs), which 
are powerful mitogenic stimulants for osteoblasts (Marie et al., 2003). FGF signaling 
has been shown to activate extracellular signal-regulated kinase (ERK), p38, c-Jun 
N-terminal kinase (JNK), protein kinase C (PKC) and phosphatidylinositol 3-kinase 
(PI3K) pathways to transduce cell signaling in osteoblasts (Deng et al., 2008). 
Furthermore, basic FGF (bFGF) was shown to induce ALP activity in rat bone 
marrow precursor cells and to induce the expression of Runx-2 (Woei Ng et al., 
2007). OCN expression can be also regulated by the FGF family member during the 
matrix mineralization stage (Deng et al., 2008). 
Endocrine control of osteoblast differentiation is regulated by two principal hormonal 
factors, parathyroid hormone (PTH), which is synthesized by parathyroid gland. The 
second is leptin produced by adipocytes. Facilitating calcium absorption from the 
small intestine would clearly serve to elevate blood levels of calcium. PTH stimulates 
this process, but indirectly by stimulating production of the active form of VD3 in the 
kidney. VD3 induces synthesis of a calcium-binding protein in intestinal epithelial 
cells that facilitates efficient absorption of calcium into blood. PTH also affects the 
expression of RANKL and M-CSF molecules that support osteoclastogenesis. At the 
same time, PTH inhibits the expression of RANKL-binding receptor, which then 
prevents RANKL binding to RANK. On the other hand, leptin acts as a physiological 
inhibitor of bone formation. This inhibition is achieved by leptin action on a 
subpopulation of hypothalamic neurons, which then acts through the sympathetic 
nervous system and β2 adrenergic receptors present on osteoblasts. Mice lacking 
leptin or leptin receptor gene have increased bone formation (Karsenty et al., 2006). 
 
1.3.4 Extracellular matrix of bone and mechanism of mineralization 
Collagen is the major protein constituent of bone and comprises about 90% of the 
protein matrix of bone tissue. Bone is primarily composed of Col I, which forms a 
fibrillar network in the ECM, imparting strength to the tissue to withstand compressive 
and tensile stress. An important part of the ECM is also composed of non-
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collagenous glycoproteins and proteoglycans (NCP), secreted by osteoblasts into the 
surrounding milieu. These anionic complexes have a high ion-binding capacity and 
are thought to play an essential role in the calcification process and the fixation of 
hydroxyapatite crystals to collagen fibers. Some of the important NCPs are listed in 
Table 1.  
 
Non-collagens glycoprotein and proteoglycans 
small integrin binding 
ligand N-linked 
glycoproteins 
cell matrix modeling 
proteins 
GLA-carboxylated 
other specialized 
proteins 
OPN 
BSP 
ON OCN 
matrix Gla 
laminin 
fibronectin 
tenascin 
vitronectin 
integrins 
serum proteins 
 
 
 
 
 
 
proteoglycans (PGs): 
biglycan 
decorin 
osteoadherin 
aggrecan 
versican 
cell-surface PGs 
CD44 glycan 
basement membrane PGs, 
intracellular PGs 
 
Table 1. List of NCPs produced by osteoblasts  
 
One of the most abundant NCPs in bone is ON, expressed in adult and embryonic 
tissues. As an acidic protein it has a high affinity for binding collagen and calcium 
ions (Termine et al., 1981). At an early stage of osteogenic development, osteoblasts 
secrete OPN, which is expressed by proliferating osteoprogenitors prior to other 
matrix proteins including BSP and OCN (Sodak et al., 2000). BSP is involved in the 
nucleation of hydroxyapatite at the mineralization stage. OCN is a member of the Gla 
protein family, highly conserved and only associated at the latest stages of osteoblast 
development. That way it provides an ideal marker for mature osteoblasts. 
Mineralization of the matrix is also initiated by expression of the membrane-bound 
glycoprotein ALP, which is assumed to play a role in the early stages of osteogenic 
differentiation.  
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Bone mineralization involves a well orchestrated process in which crystals of calcium 
phosphate (hydroxyapatite) are produced by osteoblasts and laid down within the 
ECM. The ECM proteins stabilize the smallest mineral crystals (nuclei) and bind to 
the crystal surface. The inorganic fraction of the matrix is deposited onto the collagen 
framework, which appears to play a role in the orientation of crystal nucleators and in 
the regulation of crystal size. Another mechanism for mineralization is termed as 
matrix-vesicle mediated mineralization, in which enzyme rich membrane-bound 
matrix vesicles regulate the process. These organelles contain phosphatases that are 
involved in the nucleation. Furthermore, they are also providing a protective 
microenvironment for crystal growth. It has been proposed that matrix mediated 
mineralization occurs in dystrophic mineralization (Tanimura et al., 1983); however 
the mechanism of this type of calcification remains unclear. 
 
1.4 miRNAs and RNA interference 
The first miRNA, lin-4, was discovered in 1993 in Caenorhabditis elegans (Lee et al., 
1993). A few months later subsequent work identified let-7 as another regulatory 
RNA (Wightman et al., 1993). Lin-4 and let-7 mutant worms fail to execute certain 
developmental switches, resulting in the abnormal repetition of specific larval stages. 
Two remarkable discoveries gave new insight on miRNAs as regulatory genes. It 
turned out that let-7 is fully conserved – in size and nucleotide sequence in all 
bilaterally symmetric animals (Reinhart et al., 2000). Additional genetic studies 
performed in C. elegans and Drosophila melanogaster further support the view that 
miRNAs have crucial roles in animal development by fine-tuning acting as on-off 
switches in gene expression (Johnston et al., 2003; Li et al., 2005).  
In parallel with the identification of miRNAs, a related RNA silencing phenomenon 
termed RNA interference (RNAi) was discovered. RNAi is an evolutionarily conserved 
genetic mechanism that can degrade mRNA in response to the presence of double-
strand RNA (dsRNA) corresponding to the targeted mRNA. RNAi is triggered by 
dsRNA, which is processed to 19-25 nucleotides (nt) long short interfering RNA 
(siRNA) by a special RNase III molecule termed Dicer. siRNA can induce the 
degradation of complementary mRNA by binding to perfectly complementary regions. 
Silencing mechanisms by dsRNAs were first recognized as antiviral mechanisms that 
protect organisms from RNA viruses and random integration of transposable 
elements. However, silencing by miRNAs occurs at the level of translation and is 
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operable by targeting of partially complementary sequences located within the 3’UTR 
of mRNA. The miRNA pathway and RNAi phenomenon are interconnected and 
depend on the same cellular machinery. Over the past years, it has become clear 
that miRNAs are important for the development of multicellular organisms and 
investigation of their role in osteogenic differentiation will expand the understanding 
of biological function in bone formation process. 
 
1.4.1 miRNA biogenesis 
miRNA genes are transcribed by polymerase II (Pol II) to generate a stem-loop 
containing primary miRNA (pri-miRNA), which can range in size from hundreds of 
nucleotides up to kilobases (Cai et al., 2004). The pri-miRNA is processed within the 
nucleus by a multiprotein complex of which the core components are the RNase III 
enzyme Drosha and the dsRNA-binding domain (dsRBD) protein DGR8/Pasha (Denli 
et al., 2004). This complex cleaves the pri-miRNA producing ~70 nt hairpin precursor 
miRNA (pre-miRNA). The 2-nt 3’ overhang characteristic of RNase III-mediated 
cleavage is recognized by Exportin-5, which transports the pre-miRNA into the 
cytoplasm via a Ran-GTP-dependent mechanism (Bohnsack et al., 2004). Next, the 
pre-miRNA is cleaved to produce the mature ~19-25 nt miRNA duplex by Dicer. The 
miRNA strand with the lower relative stability of base-pairing at its 5’ end is 
incorporated into the RNA-induced silencing complex (RISC), whereas the second 
miRNA strand is degraded (Schwarz et al., 2003; Du et al., 2005). 
 
1.4.2 miRNA mechanism of silencing 
The RISC complex that is involved in miRNA silencing (miRISC) contains an 
Argonaute protein, capable of endonucleolytic cleavage. Argonaute proteins bind to 
the miRNAs and their target mRNAs and accumulate in precursory bodies (P-
bodies). P-bodies are known as sites of mRNA degradation, to exclude ribosomal 
components and serve as a storage place for mRNAs. In the mode of miRNA 
repression, target mRNAs are not actively degraded, but can be destabilized owing to 
deadenylation and subsequent decapping (Wu et al., 2006). One miRNA may have 
several target sites in the 3’UTR of a single mRNA. The reduction of mRNA 
abundance is a consequence of accelerated deadenylation of targeted transcripts 
and this process seems independent of translational inhibition, indicating that 
miRNAs repress mRNAs by independent mechanisms (Giraldez et al., 2006). 
1 Introduction 15 
 
     
                 
 
Figure 2. Biogenesis and mechanism of action of animal miRNAs (Nature Reviews, Cancer, 261, 
2006)   
 
1.4.3 miRNA function 
Several recent studies suggest that miRNAs are indeed involved in the regulation of 
differentiation. Undifferentiated or poorly differentiated cells do not require miRNAs to 
survive (Wienholds and Plasterk, 2005). This is apparent from the fact that mouse 
ESCs that do not form miRNAs are viable, but fail to differentiate (Kanellopoulou et 
al., 2005). miRNAs are also not essential for tissue fate establishment during early 
development, however, inducing the loss of all miRNAs in mice by depleting Dicer 
caused arrested development during gastrulation before the body plan was fully 
configured (Bernstein et al., 2003) suggesting that miRNAs are crucial for early 
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vertebrate development. In addition, disruption of Dicer in growing oocytes in mouse 
caused failure to progress through the first cell division, suggesting that maternal 
miRNAs might be essential for mouse zygotic development (Tang et al., 2007). 
 
1.4.4 miRNA expression in ESCs 
Expression profiles of miRNAs in ESCs are different from other tissues thereby 
suggesting their involvement in self-renewal and pluripotency. A murine miR-290 
cluster (miR-290, miR-290-5p, miR-290-3p, miR-291a-3p, miR-291a-5p, miR-291b-
3p, miR-291b-5p, miR-292, miR-293, miR-294 and miR-295) is organized as a gene 
cluster on chromosome 7. Expression of this cluster increased during preimplantation 
development and remained high in undifferentiated ESCs, but decreased after ESC 
differentiation (Houbaviy et al., 2003; Houbaviy et al., 2005). The functional 
importance of the miR-290 cluster in embryogenesis has been demonstrated in a 
study, in which the generation of a mouse mutant with a homozygous deletion of the 
miR-290 cluster resulted in the death of the embryos (Ambros et al., 2007). 
Additionally, there is strong evidence that the miR-290 family is regulatory in ESCs 
maintenance and differentiation (Benetti et al., 2008; Sinkkonen et al., 2008). It is 
interesting to note that the key transcriptional factors Oct-4, Sox-2 and Nanog are 
associated with promoters for miRNAs that are preferentially expressed in ESCs, 
including the miR-290 cluster (Marson et al., 2008). In fact, the miR-290-295 cluster 
seems to be responsible for the requirement of Dicer in ESC differentiation. Similarly, 
in human ESCs two miRNA gene clusters were identified, the first contains eight 
miRNA genes (miR-302*, miR-302b, miR-302c, miR-302c*, miR-302a, miR-302a*, 
miR-302d, miR-367) and another four (miR-371, miR-372, miR-373 and miR-373*) 
(Barroso-del Jesus et al., 2008). In contrast, several miRNAs are rare in mouse 
ESCs, but abundant in differentiated cells. This includes miR-15a, miR-16, miR-19b, 
miR-92, miR-93, miR-96, miR-130 and miR-130b. Furthermore, miR-21 and miR-22 
are expressed in undifferentiated ESCs and their expression levels increased 
dramatically upon differentiation (Houbaviy et al., 2003, Suh et al., 2004). 
Interestingly, recent studies show that the transcription of miR-21 itself is regulated in 
ESCs by REST, which targets Nanog, Sox-2 and Oct-4 and directly interacts with the 
miR-21 gene (Singh et al., 2008).  
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1.4.5 miRNAs and osteogenic differentiation 
Although miRNAs are known to act as regulators in many biological and pathological 
processes, there were no reports that describe osteogenesis-regulating miRNAs until 
2008. Mizuno et al. first described that miR-125b negatively regulated osteogenic 
differentiation by mediating cell proliferation and activity of ALP (Mizuno et al., 2008). 
Subsequent reports showed that miR-133 and miR-135 inhibit BMP-2-induced 
osteogenic differentiation by directly targeting Runx-2 and SMAD-5, a key transducer 
of BMP-2 (Li et al., 2008). In addition, miR-133 also regulates expression of 
osteoblast marker genes, such as ALP and OCN. More recently, the group of Mizuno 
identified a pro-osteoblast differentiation-related miRNA, miR-210, which was up-
regulated during osteogenic differentiation (Mizuno et al., 2009). Their results 
indicated that miR-210 targets the TGFβ/Activin signaling pathway. When this 
cascade is activated, signals are transmitted to the receptor-regulated SMADs, 
SMAD-2/3. Through their phosphorylation the transcription of genes that function as 
inhibitory regulators of proliferation is activated. Inhibition of SMAD-2/3 activates 
SMAD-1/5/8 signaling and accelerates osteoblast differentiation.  
Luzi et al demonstrated that miR-26a is involved in osteogenic differentiation by 
modulating SMAD-1 mRNA and with that the level of the respective protein (Luzi et 
al., 2008). miR-26 is barely expressed in undifferentiated cells, but under 
differentiation conditions, its expression level increases, reaching a maximum when 
osteogenic maturation occurred. Conversely, SMAD-1 is highly expressed in cells 
with low miR-26 level, whereas SMAD-1 down-regulation coincided with miRNA 
induction during terminal differentiation. It has also been proven that inhibition of miR-
26a resulted in up-regulation of the SMAD-1 protein without affecting the level of 
SMAD-1 mRNA (Pillai et al., 2007).  
The relationship between the expression of miR-141, miR-200a and osteogenesis 
was also investigated by miRNA profiling of BMP-stimulated pre-osteoblast MC3T3-
E1 cells (Itoh et al., 2009). Based on this study, it has been observed that these 
miRNAs remarkably modulated the BMP-2-induced pre-osteoblast differentiation 
through targeting Distal-less homeobox 5 (Dxl-5). Shirakabe et al. reported previously 
that Dxl-5 and Msx homeobox 2 regulate the transcriptional activity of Runx-2 
(Shirakabe et al., 2001). Moreover, a recent observation by Huang et al. revealed 
that expression levels of Runx-2 are regulated by miR-204 in mesenchymal 
progenitor cells (Huang et al., 2010). Inhibition of miR-204 significantly elevated 
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Runx-2 protein levels, demonstrating that this miRNA is an endogenous attenuator of 
Runx-2 expression to prevent cells from differentiating into osteoblasts. Additionally, 
it has been demonstrated that nephronectin can affected osteogenesis (Kahai et al., 
2009). Nephronectin was discovered in developing mouse kidneys as a novel ligand 
for integrin α8β1. Kahai’s group presented evidence that overexpression of 
nephronectin enhanced osteoblast differentiation of MC3T3-E1 cells. Furthermore, 
they found that miR-378 up-regulated nephronectin expression and enhanced 
nephronectin glycosylation and secretion via binding to the 3’UTR of nephronectin 
mRNA. Interaction of miR-378 with nephronectin 3’UTR arrested this miRNA and 
freed another miR-378 target GalNT7, an enzyme essential for nephronectin 
glycosylation. As a consequence, nephronectin glycosylation was elevated and 
osteoblast differentiation was promoted.  
 
1.4.6 miRNA regulation of Wnt signaling  
Signaling complexes are highly dynamic molecular ensembles, which are the ideal 
targets for determining the degree of quantitative functions imposed by miRNAs. 
During embryonic development a handful of signaling pathways precisely coordinate 
tissue induction, pattering and morphogenesis. Members of the Wnt gene family 
serve as important developmental signaling molecules and have been implicated to 
play crucial roles in these diverse processes, among them osteoblast specification 
(Day et al., 2005; Davis and zur Nieden, 2008). For example, in the absence of 
CatnB, osteoprogenitors fail to express the transcription factor Osx and instead 
differentiate into chondrocytes.  
Because of its importance, it is not surprising that Wnt/CatnB signaling is controlled 
by miRNAs. Indeed, miR-8, the D. melanogaster ortholog of the vertebrate miR-200 
family, has been identified as a negative regulator of Wnt signaling. In mouse, miR-
200c contributes to the default signaling repression by targeting upstream positive 
modulators of the pathway (Saydam et al., 2009). Furthermore, Saydam et al. 
demonstrated that miR-200a directly targets CatnB mRNA and inhibits Wnt signaling 
in epithelial-mesenchymal transition, a process leading to the specification of 
mesoderm (Saydam et al., 2009). Similarly, however, evidence has been provided 
that miRNA expression can be induced by canonical Wnt signaling in osteoblasts 
(Kapinas et al., 2009). It is well established that the synthesis of the extracellular 
matrix and the expression of extracellular matrix genes is decreased as osteoblasts 
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become more differentiated. Conversely, as osteoblasts differentiate, the expression 
of genes important for the activation of canonical Wnt signaling is increased. Their 
observations correlate with these gene expression patterns in that miR-29, a negative 
regulator of ECM gene expression, is lowest during the cell proliferation/matrix 
deposition phases of osteoblastic differentiation. Later, as osteoblasts become more 
mature and Wnt signaling increases, miR-29 levels increase, likely in part due to an 
increase in canonical Wnt signaling. Taken together, multiple miRNAs work in 
concert to regulate related targets in common pathways. Therefore, pathway 
analysis, rather than individual target gene characterization, may provide a better 
solution to evaluate the biological consequences of global miRNA deregulation.  
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2. Aims of this study 
Diseases that involve bone degeneration, such as osteoporosis, Paget’s disease and 
osteogenesis imperfecta are extremely common. Therefore, elucidating the molecular 
events governing the processes of normal bone formation and remodeling, thereby 
identifying endogenous therapeutic targets is of extreme importance for improving 
these treatment strategies.  
miRNAs are perfect candidates to serve as therapeutic targets. Although miRNAs are 
known to act as regulators in many biological and pathological processes, until 2008 
there were no reports that describe osteogenesis-regulating miRNAs. Therefore, the 
aim of this study is to understand the functions of miRNAs in osteogenic 
differentiation using ESCs as an in vitro model for embryonic development. This is 
possible, because ESCs when differentiated into osteoblasts in culture undergo all 
stages of development including epithelial-mesenchymal transition, gastrulation, 
mesenchymal commitment, osteoprogenitor specification and mineralization. Once 
identified, manipulating the expression levels of such osteogenic miRNAs in stem 
cells in vitro may be used to enhance the generation of stem cell-derived osteoblasts 
for cell replacement therapies. Better characterization of miRNA expression in 
osteogenesis may also contribute to the identification of miRNA target genes.  
The specific aims of this thesis project are: 
• Generating the miRNA expression profile of ESCs differentiated into 
osteoblasts using the miRNA microarray method 
• Identifying and validating differentially regulated miRNAs 
• Searching for the effect of miRNA levels manipulation on osteogenic 
differentiation 
• Identifying miRNA target genes using a combined approaches: bioinformatic 
target prediction, mRNA expression analysis and TurboGFP reduction utilizing 
the p2FP-RNAi vector to trace RNA interference upon miRNA overexpression 
In summary, the aim of this study is the characterization of a miRNA expression 
pattern to provide a starting point for future functional analysis of osteogenesis 
specific miRNAs and to guide identification of miRNA/target mRNA interactions.  
 
3 Materials 21 
3 Materials 
Chemicals for experiments were purchased from the following companies, unless 
indicated otherwise: ABgen, Ambion, Applied Biosystem, Combimatrix, Evrogene, 
OligoEngine, Diagnostic Chemicals Limited, Biotech, BD Biosciences Gibco, Sigma, 
Invitrogen, Fermentas, BioLabs, Roche, BioRad.  
 
3.1 Enzymes, Kits and Transfection Reagents: 
• Alkaline phosphatase kit (Sigma) 
• Arsenazo III kit (Diagnostic Chemicals Limited) 
• DC protein kit (BioRad, Laboratories) 
• Effectene transfection reagent (Qiagen) 
• Fugene 6 transfection reagent (Roche) 
• GenElute PCR Clean-up kit (Sigma) 
• Mirus Label IT miRNA Cy5 labeling kit (Combimatrix) 
• Microplate Reader Infinite M1000 (Tecan) 
• Plasmid-Mini kit (Qiagen) 
• Plasmid-Maxi kit (Qiagen)  
• peqGOLD Universal agarose (Peqlab) 
• PureLink miRNA Isolation kit (Invitrogen) 
• QIAquick Gel Extraction kit (Qiagen) 
• QIAquick Nucleotide removal kit (Qiagen) 
• Restriction endonucleases (Fermentas) 
• RNA Nano 6000 kit (Agilant Technologies) 
• Shrimp Alkaline Phosphatase (SAP) (Fermentas) 
• SuperScript II Reverse Transcription kit (Fermentas) 
• SYBR-Green PCR Mix (ABgene) 
• T4 DNA Ligase (Fermentas) 
• TaqMan 2x Universal PCR Master Mix (Applied Biosystems) 
• TaqMan Gene Expression assay (Applied Biosystems) 
• TaqMan microRNA Reverse Transcription kit (Applied Biosystems) 
 
3.2 Equipment 
• 7900HT Real-Time PCR system Instrument (Applied Biosystems) 
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• Accuri C6 flow cytometer (Accuri Cytometers) 
• 2100 Bioanalyzer (Agilent Technologies) 
• Casy counter (Schärfe System) 
• Cell incubator HereCell 240 (ThermoElectron Corporation) 
• Centrifuges: MultiFuge 3SR+ (Heraeus), 5415R (Eppendorf) 
• DMIL microscope (Leica) 
• FC-500 cytometer (Beckman Coulter) 
• Fluorescent microscope  Observer Z1 (Zeiss) 
• Gel electrophoreses Peqlab (Biotechnology) 
• Infinite M1000 (Tecan) 
• Light Cycler 480 (Roche) 
• ND1000 Spectrophotometer (NanoDrop Technologies) 
• pH Meter Lab 870 (Schott Instruments) 
• Sectored array chambers 4×2K (Combimatrix) 
• Thermocycler (T Professional, Biometra) 
 
3.3 Software 
• Adobe Photoshop  
• AxioVision Release v.4.7.2  
• 2100 Bioanalyzer Expert software (Aligent Technologies) 
• BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) 
• FCS Express (DeNovo Software) 
• Gene Pix Pro 6.1 software (Molecular Devices) 
• Leica Software v. 1.4.0 (Leica Application Suite) 
• Microsoft Windows XP Professional 
• miRanda software (http://www.microrna.org/) 
• miRNA database (http://www.sanger.ac.uk/Software/Rfam/mirna/) 
• NCBI database (http://www.ncbi.nlm.nih.gov/) 
• PicTar (http://pictar.bio.nyu.edu/cgi-bin/new_PicTar_mouse.cgi) 
• Primer3 program (http://frodo.wi.mit.edu/) 
• SigmaPlot 11.0 statistical software (Systat Software Inc) 
• TargetScan software (http://genes.mit.edu/targetscan) 
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• Vector NTI Advance (Invitrogen) 
 
3.4 Cell lines 
3.4.1 ESCs 
The murine ESC line D3 was purchased from American Type Culture Collection, 
Rockville, Maryland, USA and are pluripotent cells derived from a blastocyst of the 
129/SV mouse strain (Doetschman et al., 1985). 
 
3.4.2 HeLa 
The human cervix carcinoma cell line (HeLa ACC 57) was purchased from DSMZ, 
Germany. The HeLa cell line was originally established from the epitheloid cervix 
carcinoma of a 31-year-old woman in 1951.  
 
3.4.3 Bacteria 
DH5α competent E. coli were purchased from Invitrogen. Genotype: F- φ80lacZΔM15 
Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rk-, mk+) phoA pE44 thi-1 gyrA96 
relA1 λ-. 
 
3.5 Cell culture media 
3.5.1 ESC expansion medium 
       Concentration  Company 
DMEM          Invitrogen 
FCS       15%   PAN  
non-essential amino acids (NEAA)   1%   Invitrogen 
β-mercaptoethanol     0.1mM   Invitrogen 
Penicillin      50 Units/ml  Invitrogen 
Streptomycin      50µg/ml  Invitrogen 
LIF       1000 Units/ml  Millipore 
 
3.5.2 ESC differentiation medium 
       Concentration  Company 
DMEM          Invitrogen 
FCS       15%   PAN  
NEAA       1%   nvitrogen 
β-mercaptoethanol     0.1mM   Invitrogen 
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Penicillin      50 Units/ml  Invitrogen 
Streptomycin      50µg/ml  Invitrogen 
 
3.5.3 Osteogenic differentiation medium 
       Concentration  Company 
DMEM          Invitrogen 
FCS       15%   PAN  
NEAA       1%   Invitrogen 
β-mercaptoethanol     0.1mM   Invitrogen 
Penicillin      50 Units/ml  Invitrogen 
Streptomycin      50µg/ml  Invitrogen 
βG       10 mM   VMR 
AA       25 µg/ml  Sigma 
VD3       5x10 -8M  Sigma 
 
3.5.4 HeLA maintenance medium 
       Concentration  Company 
DMEM          Invitrogen 
FCS       15%   PAN  
Penicillin      50 Units/ml  Invitrogen 
Streptomycin      50µg/ml  Invitrogen 
 
3.5.5 Buffers and solutions 
PBS:        8g of NaCl 
       0.2g of KCl 
       1.44g of Na2HPO4 
      0.24g of KH2PO4  
DEPC- water:      Invitrogen 
50xTAE:      2 M Tris-acetate 
       50 mM EDTA, pH 8.0 
TE Buffer:      10 M Tris-Cl 
       1 mM EDTA, pH 8.0 
Pre-hybridization solution:                         6x SSPE,  
      1% SDS  
      0,2% BSA 
6X SSPET wash solution:     6X SSPE,  
      0.05% Tween-20 
3X SSPET wash solution:     3X SSPE,  
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      0.05% Tween-20 
0.5X SSPET wash solution:     0.5X SSPE,  
      0.05% Tween-20 
Hybridization solution:      6X SSPE,  
      0.8% BSA,  
      12% DI Formamide, 
      2.5% SDS 
RIPA buffer:      1% NP40  
                                                                  0.5% Na-deoxycholate 
                                                       0.1% SDS in PBS 
Gel loading buffer 6x:      3ml glycerol   
      25mg bromophenol blue  
      dH2O to 10mL  
Annealing buffer:      100mM NaCl 
       50mM HEPES, pH7.4 
LB medium:       10 g bacto tryptone  
      5 g bacto yeast extract  
      10 g NaCl  
                                                                  dH2O to 1 litre                                                
 
3.6 Oligonucleotide sequences  
Sequences used in this study are summarized in Table 2, 3, 4 and 5. 
 
3.6.1 LNA oligonucleotides 
LNA (Locked Nucleic Acid) contain a methylene bridge that connects the 2’-oxygen of 
ribose with the 4’-carbon. The bridge results in a locked 3’-endo conformation, 
conferring enhanced hybridization performance and exceptional stability (Dwaine et 
al., 2001). 
 
Name Probe sequence 
mmu-miR-361 GTACCCCTGGAGATTCTGATAA 
mmu-miR-665 AGGGACCTCAGCCTCCTGGT 
scramble-miR GTGTAACACGTCTATACGCCCA 
mmu-miR-183 AGTGAATTCTACCAGTGCCATA 
mmu-miR-293 ACACTACAAACTCTGCGGCACT 
mmu-miR-690 TTTGGTTGTGAGCCTAGCCTTT 
 
Table 2.  LNA modified miRNA oligonucleotides used for transfection. 
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3.6.2 PCR primers 
Primers were designed using Primer 3 and Vector NTI Advance (Invitrogen) 
programs and analyzed in BLAST for specificity. 
 
Name 
Forward primer 
(sequence 5’-3’) 
Reverse primer 
(sequence 5’-3’) 
T°C bp 
Oct-4 GCCTTGCAGCTCAGCCTTAA CTCATTGTTGTCGGCTTCCTC 61 81 
T-Bra CCGGTGCTGAAGGTAAATGT CCTCCATTGAGCTTGTTGGT 60 248 
NF-68 AGTGGCTTTCTGGCTTGCTG TCTGTGTGATTCACATTGCCATAG 59 81 
CD-271 CAACCAGACCGTGTGTGAAC GGAGAACACGAGTCCTGAGC 60 235 
5T4 AACTGCCGAGTCTCAGATACC ATGATACCCTTCCATGTGATCC 55 506 
GAPDH GCACAGTCAAGGCCGAGAAT GCCTTCTCCATGGTGGTGAA 60 151 
Prickle-1 ATGGATTCTTTGGCGTTGTC GTGCAGCATGGAAGAGTT 51 159 
Dvl-1 CCTGGGACTACCTCCAGACA GGAGTCTGTGATGCTGCTGA 54 220 
OCN CCGGGAGCAGTGTGAGCTTA TAGATGCGTTTGTAGGCGGTC 60 81 
Cbfa-1 CCGAGTCATTTAAGGCTG-CAA TGCGCTGAAGAGGCTGTTT 58 101 
BSP CAGAGGAGGCAAGCGTCACT CTGTCTGGGTGCCAACACTG 62 81 
Nfatc-3 GCAATCTCCTTGCCACTCTC GGTGAAAGGGAACCAGCATA 53 153 
Fzd-3 CCAGGAACCTGACTTTGCTC GACACTCCCTGCTTTGCTTC 54 154 
FoxO-3 GGGGAGTTTGGTCAATCAGA GCCTGAGAGAGAGTCCGAGA 55 193 
Wnt8a TCGTGGACAGTTTGGAGAAA AGATGCCATGACACTTGCAG 53 120 
Pitx-2 AGCTGTGCAAGAATGGCTTT TGAGAGGACAGGGGATTGAC 53 175 
CatnB-1 GTACGCTTTTTGTTCTGGTCCT CTAGGGTTTGATAACGCCATCT 54 121 
WIF-1 GCGTGTTGGATGTTCAAATG TGTCCCAAAAGGACTGAAGG 52 164 
Dkk-1 CCCATGAACTCAGGTCCATT AATCACTTGCTTGGGCATTC 52 152 
RhoA AAGGACCAGTTCCCAGAGGT TGTCCAGCTGTGTCCCATAA 54 110 
 
Table 3. Primers sequences used for cDNA amplification. 
 
Name Sequence T°C kb 
3’UTR-Prickle-1 fwd AGATCTCCAAGTAGACATGGAGAGTCTTTGTT 
54 1.3 
3’UTR-Prickle-1 rev GTCGACGCCTTTATTAAACACCTCCCTGAAAA 
3’UTR-SFRP-4 fwd AGATCTTTACTTTCTGTGATGGAGCCACCCTTAC 
58 0.4 
3’UTR-SFRP-4 rev GTCGACAAGTATCATTTCCCCTGCCTTTATCAAA 
3’UTR-NFATc-3 fwd AGATCTTCAGTAGTCTTTGAAGCAAGTATCCTG 
55 1.7 
3’UTR-NFATc-3 rev GTCGACGACTGTTGATCTGTCACTGTTTATTATGTC 
pSuper::colony fwd AAG ATG GCT GTG AGG GAC AG  60 4.7 
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pSuper::colony rev CAG GAA ACA GCT ATG AC  
 
Table 4. Primers sequences used in miRNA predicted target cloning. 
 
3.6.3 Oligonucleotides of mature miRNA sequences 
 
Name Sequence 
miR-361 fwd GATCCCCttatcagaatctccaggggtacTTCAAGAGAgtacccctggagattctgataaTTTTTA 
miR-361 rev AGCTTAAAAAttatcagaatctccaggggtacAAGTTCTCTgtacccctggagattctgataaGGG 
miR-665 fwd GATCCCCaccaggaggctgaggtccctTTCAAGAGAagggacctcagcctcctggtTTTTTA 
miR-665 rev AGCTTAAAAAaccaggaggctgaggtccctAAGTTCTCTagggacctcagcctggtGGG 
scramble fwd GATCCCCccaacaaccgttctcagaaaTTCAAGAGAtttctgagaacggttgttggTTTTTA 
scramble rev AGCTTAAAAAccaacaaccgttctcagaaaAAGTTCTCTtttctgagaacggttgttggGGG 
miR-22 fwd GATCCCCaagctgccagttgaagaactgtTTCAAGAGAacagttcttcaactggcagcttTTTTTA 
miR-22 rev AGCTTAAAAAaagctgccagttgaagaactgtAAGTTCTCTacagttcttcaactggcagcttGGG 
miR-127 fwd GATCCCCtcggatccgtctgagcttggctTTCAAGAGAagccaagctcagacggatccTTTTTA 
miR-127 rev AGCTTAAAAAtcggatccgtctgagcttggctAAGTTCTCTagccaagctcagacggatccGGG 
miR-130a fwd GATCCCCcagtgcaatgttaaaagggcatTTCAAGAGAatgcccttttaacattgcactgTTTTTA 
miR-130a rev AGCTTAAAAAcagtgcaatgttaaaagggcatAAGTTCTCTatgcccttttaacattgcactgGGG 
miR-183 fwd GATCCCCtatggcactggtagaattcactTTCAAGAGAagtgaattctaccagtgccataTTTTTA 
miR-183 rev AGCTTAAAAAatggcactggtagaattcactAAGTTCTCTagtgaattctaccagtgccataGGG 
miR-291b-5p fwd GATCCCCgatcaaagtggaggccctctccTTCAAGAGAggagagggcctccactttgatcTTTTTA 
miR-291b-5p rev AGCTTAAAAAgatcaaagtggaggccctctccAAGTTCTCTggagagggcctccactttgatcGGG 
miR-293 fwd GATCCCCagtgccgcagagtttgtagtgtTTCAAGAGAacactacaaactctgcggcactTTTTTA 
miR-293 rev AGCTTAAAAAagtgccgcagagtttgtagtgtAAGTTCTCTacactacaaactctgcggcactGGG 
miR-300 fwd GATCCCCtatgcaagggcaagctctcttcTTCAAGAGAgaagagagcttgcccttgcataTTTTTA 
miR-300 rev AGCTTAAAAAatgcaagggcaagctctcttcAAGTTCTCTgaagagagcttgcccttgcataGGG 
miR-467b fwd GATCCCCgtaagtgcctgcatgtatatgTTCAAGAGAcatatacatgcaggcacttacTTTTTA  
miR-467b rev AGCTTAAAAAgtaagtgcctgcatgtatatgAAGTTCTCTcatatacatgcaggcacttacGGG 
miR-690 fwd GATCCCCaaaggctaggctcacaaccaaaTTCAAGAGAtttggttgtgagcctagcctttTTTTTA 
miR-690 rev AGCTTAAAAAaaaggctaggctcacaaccaaaAAGTTCTCTtttggttgtgagcctagcctttGGG 
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Table 5. Oligonucleotide sequences used for cloning the pSuper.miRNA reconstitution vectors. 
The backbone sequence, yielding the stem and loop structure is given in capital letters, the individual 
miRNA sequences in small letters. 
 
3.7 Enzymes and reaction buffers  
Restriction enzymes Bgl II, Hind III,, Sa lI, and BamH I and associated buffers, Taq 
DNA polymerase and 10x PCR buffer, 10x dephosphorylation buffer, 10x ligation 
buffer, T4 DNA ligase, SAP and 100x BSA were supplied by Fermentas. 
 
3.8 Plasmids 
Plasmid pSuper.neo and p2FP-RNAi were derived from OligoEngine and Evrogen, 
respectively.  
 
3.8.1 Plasmid constructs used for this work: 
pSuper.miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, miR-293, miR-300, 
miR-361, miR-467b, miR-665, miR-690, miR-scr, p2FP-RNAi.Prickle-1, p2FP-
NFATc-3. 
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Figure 3. Map of the pSuper.neo cloning vector. Shown is the position of the multiple cloning site 
(MCS) under the control of the H1 promoter. The ampicillin resistance gene is the selectable marker, 
which was used to select for successfully transformed bacterial cells. Map was produced using 
www.infosake.com. 
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Figure 4. Map of p2FP-RNAi cloning vector. Shown is the position of the MCS under the control of 
the H1 promoter. The kanamycin resistance gene is the selectable marker, which was used to select 
for successfully transformed bacterial cells. Map was produced using www.infosake.com. 
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4 Methods 
4.1 Cell biology 
4.1.1 Mouse ESC line D3 and HeLa cell culture maintenance  
All cell types were cultured at 37ºC in a humidified incubator with 5% CO2. 
 
4.1.1.1 Murine ESCs 
Murine ESCs were maintained in DMEM supplemented with 15% FCS (Invitrogen, 
selected batches), 2mM L-glutamine, 1% NEAA, and 0.1mM ß-mercaptoethanol with 
the additive LIF (1000U/ml) (Millipore). To passage, cells were removed from the 
culture dish surface with a 0.25% trypsin/EDTA solution (Gibco). Cells were detached 
from the wells by incubation with trypsinization solution for approximately 2min at 
37ºC. Trypsinization was stopped by adding equal amounts of ESC medium. 
Detached cells were counted in a Casy counter (Schärfe System) and transferred 
into a 15ml Falcon tube and pelleted in a centrifuge (MultiFuge 3SR+, Heraeus)  at 
800rpm for 5min. They were resuspended in fresh medium and seeded in number of 
1.2x104 cells per cm2. The cultured D3 cells were examined on a daily basis under 
phase contrast microscope and passaged every 2nd day.  
 
4.1.1.2. HeLa cells 
HeLa cells were grown as adherent monolayers in DMEM supplemented with 10% 
FBS (Biotech), 2mM glutamine, 50U/ml penicillin and 50μg/ml streptomycin. The 
medium was changed twice a week.  
 
4.1.2 Thawing of cryo-preserved cells 
Frozen cells were quickly placed in a water bath at 37°C until the freezing medium 
was thawed. Cells were than added to pre-warmed growth medium (approximately 
10 times the volume of the cryo-culture) and centrifuged for 5min at 800rpm. The cell 
pellet was resuspended in growth medium and seeded in a well or culture flask.  
   
4.1.3 Counting cells 
To perform cell counts, 10µl of cells in suspension were diluted in standardized buffer 
(Casyton) (Schärfe System) in a ratio of 1:1000 and counted using an electronic 
device Cell Counter+Analyzer System Model TTC (Schärfe System).  
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4.1.4 Cryo-preservation of cells 
In order to store cell lines for a longer period of time cells were trypsinized and 
resuspended in pre-warmed growth medium (see section 3.5.1). The cell suspension 
was centrifuged for 5min at 800rpm. The pellet was resuspended in 500μl freezing 
medium in cryogenic vials (10% DMSO in FCS), and stored at -80°C in a Mr. Frosty 
freezing container. After one day cryo-cultures were transferred to liquid nitrogen (-
196°C). 
 
4.1.5 Osteogenic differentiation of murine ESCs  
To initiate cell differentiation, ESCs were removed from the culture flask by 
incubation with 0.25% trypsin/EDTA solution for approximately 3min at 37ºC. Cells 
were counted with a CASY cell counter (see section 4.1.4). Cells were differentiated 
with the hanging drop method as described (zur Nieden et al., 2001). Approximately 
750 cells per 20µl of medium were dispensed in hanging drops onto the inner side of 
100mm tissue culture Petri dish lid filed with PBS. Cells condensed to form EBs were 
transferred on day 3 into bacteriological Petri dishes. On day 5, EBs were dispread 
and plated into 24- or 6-well tissue culture primaria plates (BD Biosciences) at a 
density of 5x104 cells per cm2. Osteogenic differentiation was induced by adding 
osteogenic differentiation medium (see section 3.5.3) as described for murine ESCs 
(zur Nieden et al., 2003). Spontaneously differentiating time-corresponding controls 
were grown in non-supplemented differentiation medium (see section 3.5.2). Cultures 
were maintained for 28-30 days and the medium was changed every second day.  
 
4.1.6 Protein concentration determination 
The BioRad DC-protein concentration assay kit was used to determine the 
concentration of protein samples against standard bovine serum albumin (BSA) 
solution. Aliquots (5µl) of standard BSA solution (0.01-0.07mg/ml in PBS) and protein 
samples were added in triplicates to a 96-well plate. For each plate, 25µl Reagent A 
from the kit was added and then 200µl of Reagent B were mixed. The plate was 
stored on ice for 15min for maximized color development and the absorbance of all 
wells was measured at 750nm using spectrophotometer (Infinite M1000, Tecan) 
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4.1.7 Quantitative analysis of calcium accumulation in mineralized matrix 
The enhancement of osteoblastic differentiation was investigated in experiments by 
the finding of increased calcium levels as a result of being incubated with induction 
medium. To estimate the amount of calcium, cells were lysed with RIPA buffer. 
Whole cell extract was prepared by rotation for 1h at 4°C. Protein concentration was 
determined by using the DC-Protein Kit (BioRad, Laboratories) as described above. 
The pellets and extracellular matrix leftover on the culture plates were treated with 
1M hydrochloric acid (HCl) for 16-24h at 4°C. Calcium content in HCl-supernatant 
and protein lysate was measured by using a colorimetric assay with Arsenazo III 
reagent (Diagnostic Chemicals Limited). Arsenazo III binds with calcium in an 
alkaline medium to form a purple colored complex, which absorbs maximally at 
650nm. The intensity of the color is proportional to the calcium concentration. The kit 
reagent was added into the samples in proportions of 25µl of protein lysate, 10µl of 
HCl-supernatant with 75µl and 250µl Arsenazo III, respectively (Davis et al., 2011). 
The absorbance at 650nm was measured by using a spectrophotometer (Infinite 
M1000, Tecan). The calcium amount in HCl-supernatant and protein lysate was 
normalized to the total protein content.  
 
4.1.8 Determination of ALP activity 
ALP activity was measured using a commercially available assay kit (Sigma). This kit 
measures the conversion of p-nitrophenol phosphate to p-nitrophenol and inorganic 
phosphate. The change in absorbance is directly proportional to ALP activity. Cells 
were lysed with RIPA buffer and concentration of proteins was determined (see 
section 4.1.7). In a subsequent step, the kit reagent was added to the lysates and 
absorbances were obtained at 1 and 10min. ALP activity (U/ml) was determined 
using the change in absorbance with time taking into account the millimolar 
absorption of p-nitrophenol of 18.45 at 405nm (Davis et al., 2011).  
 
4.1.9 Transient transfection with plasmid DNA and LNA-oligonucleotides 
D3 and HeLa cells were transfected with Effectene (Qiagene) and FuGene6 (Roche) 
transfection reagents, respectively. For transfection, D3 cells were harvested as 
described above (see section 4.1.2) and counted using a Casy counter (Schärfe 
System). ESCs were transfected in suspension on day 0. On day 5 of differentiation, 
EBs were disrupted, cells were counted and transfected in suspension. The third 
4 Methods 34 
transfection was repeated on day 10 of differentiation, when cells were attached and 
still not in the high density.  
On the day of transfection, 2μg of DNA or 150nmol of LNA-oligonucleotides per 
5x105 cells were diluted in DNA condensation buffer (EC buffer), to a total volume of 
100μl; 6.4μl Enhancer was added and mixed. The mix was incubated at room 
temperature for 10min, and then 8μl of Effectene was added and mixed gently. 
Samples were incubated for 10-15min at room temperature. After incubation the 
mixture was added drop-wise to the cells.  
For Hela cells, one day before transfection 105 cells were counted using a Neubauer 
chamber and plated in monolayers in each well of 24-well plates. Culture medium 
containing serum was removed and replaced by OPTI-MEM serum free medium 1h 
before transfection. 1μg of the appropriate plasmid and 3µl of FuGene6 reagent 
(Roche) were resuspended in 200µl of OPTI-MEM medium and left under the hood 
for 10min. The transfection reagent:DNA complex was added to the cells in the drop-
wise manner. Serum containing medium was replaced 16h after transfection. Cells 
were processed for FACS analysis after 48h. Transfection efficiency was verified by 
EGFP expression analysis using FC-500 cytometer (Beckman Coulter) as follows. 
 
4.1.10 Flow cytometry 
To analyze cellular DNA content, cells were fixed and FACS analysis was performed. 
106 cells were isolated by trypsin digestion, neutralized by medium containing serum 
and pelleted by centrifugation at 800rpm 5min at room temperature. Cell pellets were 
washed twice with PBS, fixed in 80%ice-cold ethanol and stored at -20°C. Prior to 
flow cytometry analysis, cells were washed with PBS. An Accuri C6 Flow Cytometer 
System with CFlow® Plus Software was used for the analysis. Control non-
transfected cells and cells transfected with p2FP-RNAi plasmid were used to gate for 
forward and side scatter. Single cell suspensions were passed through a 488nm 
laser for excitation, and fluorescence emissions were collected at 530nm (+/- 30nm) 
for TurboGFP and 585 nm (+/- 40nm) for JRed. To estimate the percentage of GFP 
or JRed positive cells parameter plots of GFP and JRed expression were gated 
versus forward scatter (FSC-A). The analysis consisted in gating of the cells on the 
FSC/SSC plot for exclusion of contaminating debris and cell doublets. Samples were 
analyzed using a fluidics rate of Slow (core size=10µm, flow rate=10µL/min) and at 
least 10,000 gated events collected per sample. 
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4.1.11 MTT assay 
This is a colorimetric assay that measures the reduction of yellow 3-(4,5-
dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) by mitochondrial 
succinate dehydrogenase. The MTT enters the cells and passes into the 
mitochondria where it is reduced to an insoluble, colored (dark purple) formazan 
product. The cells are then solubilized with an organic solvent (eg. isopropanol) and 
the released, solubilized formazan reagent product is measured 
spectrophotometrically. Since reduction of MTT can only occur in metabolically active 
cells the level of activity is a measure of the viability of the cells. For the assay, ESCs 
were transfected with pSuper miRNA constructs and plated onto gelatin coated 48-
well plates in triplicate at a density of 5x105 cells per cm2. Next, 40µl of MTT (5mg/ml) 
was added to the wells (final concentration 0.5mg/ml) for 2h after 24h and 48h post-
transfection.  Reaction was stopped by the addition of 260µl of solubilization solution.  
Reaction solution was quantified by spectrophotometry in an Infinite M1000 
microplate reader (Tecan) at 550nm with a reference wavelength of 650nm. The 
relative cell viability (percent) for ESCs was determined as a ratio of average 
absorbance for cells transfected with miRNAs to the control cells.  
 
4.2 DNA cloning 
4.2.1 Bacteria culture 
Liquid bacterial culture was performed in LB medium containing either 100μg/μl 
ampicillin or 50µg/µl kanamycin in shake flasks. Cultures were grown overnight under 
aerobic conditions at 37°C and shaking at 200rpm. Cultivation on solid LB agar 
plates was performed in the presence of ampicillin (100μg/μl) or kanamycin (50µg/µl) 
selection. Plates were incubated overnight at 37°C, bottom up. 
 
4.2.2 Bacteria Storage 
Agar cultures were stored on LB ampicilin+/kanamycin+ plates for several weeks at 
4°C. For prolonged storage, 500μl cell suspension of a liquid overnight culture were 
mixed with the same volume of glycerol and stored at -80°C in cryotubes. 
 
4.2.3 Transformation of competent bacteria 
For the transformation of competent cells DH 5-α competent E. coli (Invitrogen) were 
thawed on ice. 50μl of the competent cells were mixed with 1μl of the plasmid or the 
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5µl of the ligation reaction, and then stored on ice for 30min. Next, a heat shock was 
carried out at 37°C for 1min, followed by incubation for 2min on ice. Then, 500μl of 
LB (without antibiotics) was added, after which the sample was incubated for 1h at 
37°C. An aliquot of 200μl was plated on an LB plate containing antibiotics (either 
100μg/μl ampicillin or 50µg/µl kanamycin). The plates were incubated overnight at 
37°C, bottom up. Single colonies were analyzed by colony PCR or DNA plasmid was 
prepared.  
. 
4.2.4 Isolation of plasmid DNA 
For extraction of plasmid DNA for clone screening after ligation, single colonies of the 
transformed cells were picked from the LB plate, transferred into 5ml LB medium plus 
the individual antibiotic (either 100μg/μl ampicillin or 50µg/µl kanamycin) and 
incubated overnight at 37°C in a shaker (200rpm) under aerobic conditions. Plasmid 
preparation was performed using the Plasmid-Mini kit (Qiagen) according to the 
manufacturer’s instructions. To obtain large amounts of highly purified plasmid DNA 
the Plasmid-Maxi kit (Qiagen) was used following the manufacturer’s instructions. 
DNA concentration was determined using the ND1000 Spectrophotometer 
(NanoDrop Technologies) by measuring the optical density (OD) at a wavelength of 
260nm. 
 
4.2.5 Enzymatic digestion of plasmid DNA 
A preparative digestion reaction was set up in the following manner: 
DNA X ng 
10x buffer final conc. 1x 
Restriction endonuclease 1 1μl 
Restriction endonuclease 2 1μl 
ddH2O up to 30-50μl 
The preparation was incubated for 2-3h at 37°C. The digestion reactions were 
stopped by incubating at 65ºC for 10min. Reaction buffers and reaction temperatures 
were chosen according to the manufacturer’s recommendation. 
 
4.2.6 Dephosphorylation of digested DNA fragments 
To prevent religation of the vector DNA, samples were treated with SAP (1U/µl, 
Fermentas). 1μl of SAP was added to the digestion and incubated at 37°C for 30min. 
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4.2.7 Gel extraction of DNA fragments 
For gel extraction the preparative digests were run on an agarose gel. The specific 
bands were cut out under UV light and the DNA was then isolated using the QIAquick 
Gel Extraction kit (Qiagen) following the manufacturer’s instructions. DNA 
concentration was determined using the ND1000 Spectrophotometer (NanoDrop 
Technologies). 
 
4.2.8 Ligation of DNA fragments 
A standard ligation reaction contained the following components: 
Vector DNA 100ng 
Insert DNA X ng 
T4 DNA ligase 5U 
10x DNA ligase buffer (5x) 1μl 
ddH2O up to 10μl 
The ligation reaction was incubated overnight at room temperature. Ligations without 
the insert were used as controls. The reaction was then used for transformation. 
 
4.2.9 PCR product purification 
For purifying PCR products prior to cloning, the GenElute PCR Clean-up kit (Sigma) 
for removal of residual primers, salt and polymerase was used according to the 
manufacturer’s protocol. 
 
4.2.10 Agarose gel electrophoresis  
For separating DNA fragments according to their size, the DNA was typically applied 
to 1-3% agarose gels containing 0.5μg/ml ethidium bromide. The DNA samples were 
mixed with 6x loading buffer and separated by agarose gel electrophoresis together 
with a DNA standard (DNA Ladder, Fermentas). Gels were let run at 120V for 45min. 
The DNA bands were detected under UV light und the size was estimated by 
comparison to the marker.  
 
4.2.11 miRNA expression constructs 
To generate miRNA expression plasmids, the pSuper.vector system (Oligoengine) 
was used according to the manufacturer’s protocol. Oligonucleotides containing the 
mature miRNA sequence for miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, 
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miR-293, miR-300, miR-361, miR-467b, miR-665, miR-690 and a miR-scr as control 
were obtained from EuroGenTech. The oligonucleotides contained the specific target 
sequence, and either a Bgl II (forward primer) or a Hind III (reverse primer) restriction 
site, and a sequence that facilitates the resulting transcript to fold back on itself to 
form a 19bp stem-loop structure. For cloning 3mg/ml of the forward and reverse 
primer were annealed in annealing buffer, by heating them for 5min at 95°C and then 
stepwise cooling to room temperature. The annealed oligonucleotides were 
subsequently ligated into the Bgl II and Hind III restriction sites in the MCS of the 
pSuper.neo vector. For overexpression of miRNAs 2µg plasmid DNA was used for 
transfection. 
 
4.2.12 Predicted targets expression constructs 
To generate RNAi plasmids, the p2FP-RNAi vector was used according to the 
manufacturer’s protocol. The target 3’UTR sequences of Prickle-1, NFATc-3 and 
SFRP-4 (NCBI database, NM_001033217, NM_010901, NM_016687 respectively) 
were checked for restriction sites with sequence analysis software Vector NTI 
Advance (Invitrogen). The sense and antisense primers (see section 3.6.2) were 
designed to flank the complete translated copy DNA (cDNA) sequence of the 3’UTRs 
and contained extra restriction sites for subsequent subcloning of the PCR product 
into the MCS of the p2FP-RNAi expression vector.  
  
4.3 Molecular biology 
4.3.1 Spectrophotometric determination of DNA or RNA concentration 
DNA or RNA concentrations were determined using a ND1000 Spectrophotometer 
(NanoDrop Technologies) by measuring the OD at a wavelength of 260nm (A260). 
An OD (the ratio between an A260/A280) reading and the nucleic acid concentration 
value of 1 corresponds to: 
- 50μg/ml of DNA for double-stranded DNA 
- 40μg/ml for single-stranded DNA and RNA 
Ratio of readings at 260nm and 280nm (A260/A280) provided an estimate of the 
purity of the nucleic acid. Ratios between 1.8-2.0 were defined as pure preparations 
of DNA and RNA. 
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4.3.2 Extraction of total RNA  
Total RNA was isolated using TRI-Reagent (Sigma) in accordance with the 
manufacturer’s instructions and was highly enriched for mature miRNA species using 
a PureLink miRNA Isolation kit (Invitrogen). Cells were lysed by adding 1ml of TRI-
Reagent per 107 cells. After adding 0.2ml of chloroform, the lysate was vortexed for 
15s, incubated at room temperature for 2-3min and centrifuged at 12.000g for 15min 
at 4ºC to separate the phases. The upper aqueous phase containing RNA was 
collected in a new tube. RNA was precipitated by addition of 0.5ml of 100% isopropyl 
alcohol per 1ml of TRI-reagent and centrifuged at 12.000g for 15min at 4ºC. Pellets 
were washed with 70% ethanol and dissolved in RNAse-free water. RNA quality was 
determined using a ND-1000 Spectrophotometer (NanoDrop Technologies) against 
water blank and in the 2100 BioAnalyzer (Agilent Technologies) according to the 
manufacturer, respectively. Small RNAs (<200nt) were then isolated out of total RNA 
using the PureLink.microRNA Isolation kit (Invitrogen) according to the protocol 
provided by the manufacturer. 
 
4.3.3 BioAnalyzer analysis of RNA integrity  
Analysis of RNA integrity was performed using the Agilent BioAnalyzer and 
associated RNA NanoChip reagents according to manufacturer’s instructions. Briefly, 
after reconstitution of all reagents, the appropriate well of a NanoChip was loaded 
with 9μl of gel-dye mix and pressurized in the priming station for 30s. A further 9μl of 
gel-dye was then loaded into each of the wells marked “G”. In the remaining wells, 
5μl of RNA 6000 NanoMarker (including the ladder well) was added. 1μl of RNA 6000 
ladder was then added into the appropriate well and then 1μl of total RNA sample 
(previously incubated at 70°C for 2min) added into a sample well. The chip was 
vortexed for 1min at 2400rpm and analyzed on an Agilent 2100 BioAnalyzer within 
5min of preparation 
 
4.3.4 Reverse transcription of mRNA  
Reverse transcription polymerase chain reaction (RT-PCR) initially involves the 
extraction of RNA followed by the reverse transcription of RNA into a cDNA molecule 
by the enzyme reverse transcriptase, and finally PCR thermocycling. After heat 
denaturation of the extracted RNA molecule (to remove any secondary structure 
which may prevent primer binding) hybridization of RT primers to the RNA template is 
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allowed to occur. The whole extracted RNA pool is reverse transcribed by using non-
specific random hexanucleotide primers. In this process a library of cDNA molecules 
is generated within a single reaction mix. cDNA was either synthesized using 
SuperScript II Reverse Transcription kit (Fermentas) or a TaqMan microRNA 
Reverse Transcription kit (Applied Biosystems). 
Using SuperScript II RT kit: 625ng of total RNA, 5µM random hexamer primer, 
0.5mM dNTPs, 5mM MgCl2, 10mM DTT were mixed with 1x FS buffer (all reagent 
from Fermentas),  subsequently 80 Units of SuperScript II enzyme was added. The 
cDNA reaction was diluted with DEPC-water to a final volume of 25µl. Reactions 
were incubated in a thermocycler (T Professional, Biometra) at 25ºC for 10min, in this 
time the primer was annealed to the RNA strand. Then, reactions were heated to 
42ºC for 50min (elongation time) and next reverse transcriptase was deactivated at 
70ºC for 15min.  
Using the TaqMan micro-RNA Reverse Transcription kit: 50ng of total RNA, 
100mM dNTPs, 10x Reverse buffer, 20U/µl RNase inhibitor (Applied Biosystems ), 
3µl of specific primer and 50U/µl of MultiScribe reverse transcriptase (Applied 
Biosystems ) were mixed and diluted with nuclease-free water to the final volume 
15µl. Reactions were incubated in thermocycler at 16ºC for 30min (integration of 
primer to RNA strand), next at 42ºC for 30min (elongation time) and at 85ºC for 5min 
(deactivation of reverse transcriptase). 
cDNA was stored in -20ºC for no longer than 2 months. 
 
4.3.5 Semi-quantitative PCR  
PCR reaction (25µl) were performed using 25-50ng of cDNA, 1x PCR buffer, 100µM 
dNTPs, 2.5µM of forward and reverse primer each and 0.625 Units of Taq 
polymerase (all reagents come from Fermentas). The PCR reaction was diluted with 
DEPC water to a final volume of 25µl. The following cycle parameters were used:  
• Initial denaturation                94ºC   5min 
• Denaturation                         94ºC   45s 
• Annealing                              60ºC   45s 
• Extension                              72ºC   45s 
• Cycles                                   35-40 
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PCR products were analyzed by 1-3% agarose gel electrophoresis. A 3% agarose gel 
was prepared by mixing 3g multipurpose agarose (peqGOLD Universal agarose) 
(Peqlab) in 100ml TAE buffer. The solution was mixed in a glass 200-ml bottle and 
heated in a microwave on full power for approximately 1min to dissolve the agarose. 
Then agarose solution was supplemented with 0.5µg/ml ethidium bromide. Once set 
the gels were placed in a gel electrophoresis tank (Peqlab) and submerged in TAE 
buffer. The combs were removed and 10µl PCR amplified DNA, mixed with 6x 
loading dye, was loaded per well. The lid was placed on the gel electrophoresis tank 
and connected to a power gel electrophoresis power supply (Peqlab) then run for ~35 
to 45min at 120V. 
 
4.3.6 Real-Time PCR  
The determination of the relative expression levels of mRNA transcripts was obtained 
by two step real-time RT-PCR with an amplification program as follows: Taq 
polymerase activation 95ºC for 10min; PCR: denaturation 95ºC for 30s and 
annealing/extension 60ºC for 30s (repeated 55 times) (zur Nieden et al., 2004). All 
experiments were carried out in triplicates. Each reaction contained 12.5μl SYBR-
Green qPCR Mix (ABgene), 50ng RNA, 0.5μM of the appropriate specific primers 
and was adjusted to a 25μl reaction volume with DEPC water. Amplification and 
fluorescence detection was performed using the Light Cycler 480 (Roche).  
The relative expression levels of miRNAs were measured with a TaqMan microRNA 
assay (Applied Biosystem). sno202 small nuclear RNA, was utilized as an internal 
control for quantification of miRNAs. The primers both for sno202 and miRNAs were 
ordered as Custom TaqMan Gene Expression assays from Applied Biosystems. 
TaqMan real time PCR was prepared by using of 10µl of TaqMan 2xUniversal Master 
Mix (Applied Biosystems), 1.5µl of cDNA template and 1µl of specific primer in a total 
volume of 20µl. The following cycle parameters were used: TaqMan activation 95°C 
for 10min; PCR: denaturation 95°C for 15s, annealing/extension 60°C for 1min 
(repeated 40 times). The reaction was followed by a melting curve protocol according 
the specification of the 7900HT Real-Time PCR System Instrument (Applied 
Biosystems). All experiments were carried out in triplicate. 
The relative amounts of each RNA or miRNA product to its internal control (GAPDH 
for mRNAs and sno202 for miRNAs) were calculated using the 2-ΔΔCt, where ΔCt is 
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Ct (gene of interest) - Ct (control gene). Ct is the cycle at which the threshold is 
crossed. Sequences of all primers are provided in table 3 (see section 3.6.2). 
 
4.4 miRNA microarray analysis  
miRNA expression analysis in cell lines was performed using the sectored array 
chambers (4 chambers per array) (CombiMatrix 4×2K arrays) mouse miRNA 
microarray system. Arrays were run in duplicate for undifferentiated and differentiated 
conditions. A total of 2μg of the small RNA enriched sample (0.5μ/g per Array sector) 
was Cy5-labeled using the Mirus Bio Label ITr microRNA Labeling kit according to 
the manufacturer’s protocol. 
 
4.4.1 Labeling 
The labeling reaction was set up according to the following scheme: 
Purified small RNA enriched sample 2μg 
10x Labeling Buffer M 20μl 
Label ITr Cy5r Reagent 8μl 
Nuclease-free water ad 200μl 
The labeling reaction was incubated for 1h at 37°C and the reaction was stopped by 
addition of 0.1 volumes of 10x STOP reagent followed by vortexing. For post-labeling 
purification via ethanol precipitation 4μl of precipitation enhancer, 0.1 volume of 5M 
sodium chloride and 2.5 volumes of ice cold 100% ethanol were added to the 
labeling reaction. After mixing, the reaction was incubated at -80°C for 30min. The 
sample was centrifuged for 30min at 16,000xg and 4°C to pellet the labeled small 
RNA sample. The ethanol was discarded, and the pellet was washed with 500μl 
nuclease-free 70% ethanol (room temperature) and briefly vortexed, followed by 
centrifugation for 20min at 16,000xg and 4°C. The ethanol was removed and the 
pellet was air-dried for 5min. The pellet was resuspended in 20μl 1x Hybridization 
Solution (pre-warmed to 37°C) followed by hybridization. Hybridization and scanning 
was performed following the manufacturer’s instructions (CombiMatrix). 
 
4.4.2 Pre-Hybridization 
Arrays were placed in the hybridization clamp according to manufacturer’s 
instructions and the hybridization chambers were filled with 35μl nuclease-free water, 
sealed with adhesive tape and incubated for 10min at 65°C. The clamp was cooled 
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down to room temperature and the water aspirated out of the hybridization chambers. 
The hybridization chambers were filled with 35μl pre-hybridization solution and gently 
mixed. The solution portals were covered with adhesive tape, after which the 
microarray was loaded onto the rotisserie in the hybridization oven and incubated for 
60min at 37°C under gentle rotation. 
 
4.4.3 Hybridization 
After removing the pre-hybridization solution from the hybridization chambers, 30μl of 
the labeled RNA samples were filled into the chambers and were gently mixed by 
repeated pipetting. The solution portals were covered with adhesive tape and the 
microarrays were loaded onto the rotisserie in the hybridization oven and incubated 
at 37°C overnight under gentle rotation. 
 
4.4.4 Hybridization washing 
The microarrays were removed from the hybridization oven and the hybridization 
solution was removed from the chambers. The hybridization chambers were rinsed 
with 6x SSPET wash solution. After addition of fresh 6x SSPET wash solution, the 
arrays were incubated for 3min at room temperature in the dark. The 6x SSPET wash 
solution was removed from the hybridization chambers and the washing procedure 
was repeated once with 3x SSPET wash solution and twice with 0.5x SSPET wash 
solution. 
 
4.4.5 Scanning 
The 0.5x SSPET wash solution was discarded from the chambers and the arrays 
were removed from the hybridization clamp. The semiconductor microarray surface 
was then immediately covered with the Imaging Solution. A fresh LifterSlip.coverslip 
(Electron Microscopy Sciences) was placed over the semiconductor area and the 
arrays were scanned using a GenePix 4200 Scanner and the GenePix Pror 6.1 
Software package (Molecular Devices) with the following settings: laser power: 40%, 
PMT: 500, resolution: 5μm, focus: 85μm. 
 
4.4.6 miRNA microarray statistical analysis  
The miRNA microarrays were analyzed using R (version 2.9.0) and BioConductor 
(version 2.4) (Gentleman et al., 2005). miRNA expression levels were normalized 
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between all arrays by Quintile normalization (Bolstad et al., 2003). On Combimatrix 
miRNA microarrays each miRNA is spotted on four different spots in order to catch 
local fluctuations in expression levels on one microarray. In addition, miRNA 
sequences mutated at two nucleotides are spotted next to each miRNA, such that the 
degree of unspecific binding can be quantified. miRNAs, whose Spearman 
correlation coefficient CS reflected a strong correlation between expression profiles of 
the original and mutated miRNA sequence, in detail CS< −0.9 or CS > 0.9, were 
excluded. A linear model was fitted for each miRNA by using the R package limma 
(Smyth et al., 2004). Differentially expressed miRNAs were identified by empirical 
Bayes moderated t-statistics in order to obtain reliable variance estimations. The 
false discovery rate was controlled by Benjamini-Hochberg adjustment. 
 
4.5 Statistical analysis 
All results were expressed as mean ±S.E.M (n=3). Statistical analysis was performed 
using SigmaPlot 11.0 statistical software (Systat Software Inc). Statistical analysis 
was performed using Student t-test and p value<0.05 was used as a threshold for 
statistical significance.  
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5. Results 
5.1 The murine D3 ESC line efficiently differentiates into osteoblasts 
The controlled generation of osteoblasts into a potentially homogenous population is 
a crucial step in the advancement of ESC research from the laboratory to clinical 
application (Zweigerdt et al., 2003; Karlsson et al., 2008). Since osteoblasts are 
responsible for synthesizing bone matrix they play vital roles both in correct 
development of bones and in repairing broken bone (Olsen et al., 2000; Harada and 
Rodan, 2003; Ralston and de Crombrugghe, 2006). An understanding of the 
osteoblast differentiation pathway could potentially help in developing new ways of 
treating bone diseases and bone injuries. However, the molecular mechanisms that 
regulate osteoblast specific gene expression remain a central challenge in bone 
formation. Therefore, the experiments were initiated to identify novel miRNAs using 
the D3 ESC line, which has been previously shown to differentiate well into 
osteoblasts (zur Nieden et al., 2003). To confirm the published model, a combination 
of factors was used in order to facilitate differentiation of ESCs. Differentiation was 
monitored by changes in cellular morphology, calcium amount, ALP activity and 
expression of molecular markers.  
 
5.1.1 Morphology of mouse ESCs differentiated into osteoblasts 
The major characterization criterion for ESCs is the retained differentiation potential 
upon expansion. ESCs were expanded as described in chapter 4.1.1 and 
subsequently induced into osteoblasts through dissociation of EBs and then cultured 
as monolayer for 30 days in the presence of VD3, βGP and AA. Formation of 
mineralized matrix is one of the basic classifications of mature osteoblasts (Phillips et 
al., 2001).  Cells cultured in osteoblast inducing medium elicited a strong osteogenic 
differentiation response compared to control medium (Fig. 5A). Mineralization was 
detectable in osteogenic cultures as black coloration in phase-contrast microscopy, 
which represents calcified matrix (Fig. 5B) (zur Nieden et al., 2007). 
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Figure 5. Photomicrograph of spontaneously differentiated and osteogenically induced 
cultures of mouse ESCs. D3 cells were cultured in differentiation inducing media for 30 days. 
Mineralization can be recognized as black coloration in phase contrast microscopy. A. cells 
differentiated in control medium, B. osteoblasts, as shown by phase contrast microscopy cultured in 
VD3, βGP and AA supplemented medium. Scale bar represents 500µm. 
 
5.1.2 Calcium content and ALP activity in ESCs differentiated into osteoblasts 
An alkaline environment is necessary to force cells to secret Ca2+ incorporating 
mineralized matrix (Philips et al., 2001; zur Nieden et al., 2003). Thus, high calcium 
levels and ALP activity are established markers of osteogenic differentiation. In 
response to the osteogenic induction performed here, ESCs revealed a statistically 
significant increase of calcium content (510-fold, p<0.05) at day 30 (Fig. 6A). ALP 
activity analysis showed an insignificantly enhanced level of enzyme activity (1.6-fold, 
p<0.05) after 30 days of osteogenic stimulation (Fig. 6B). 
 
Figure 6. Calcium deposition and ALP activity during spontaneous and osteogenic 
differentiation of ESCs A. calcium content was normalized against protein content to determinate 
calcium synthesis during differentiation, B. ALP activity was normalized against protein content. Data 
are reported as mean ± SD (n=3). Significant differences from cells cultured in control medium, *, 
p<0.05 with Student’s t-test. 
 
5.1.3 Gene expression profiling 
To confirm that cells were committed to the osteogenic lineage the mRNA expression 
levels of T-Brachyury (T-Bra) and OCN were evaluated. ESCs were stimulated with 
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osteogenic factors and total RNA was extracted at day 0, 3, 5, 6, 8, 10, 15, 20, 25 
and 30 from three independent experiments. Gene expression was analyzed with 
semi-quantitative RT-PCR (see section 4.3.5) from transcribed cDNA (see section 
4.3.4) using glyceraldehyde-3 phosphate dehydrogenase (GAPDH) as loading 
control. The results from one representative experiment are shown in Fig. 7. The 
expression of T-Bra was present at very low levels in undifferentiated cells and 
evidently increased in abundance to peak at day 3 and 10 of differentiation, which 
confirms previous results (Davis and zur Nieden, 2008). OCN was strongly induced 
between day 20 and 25 in response to the osteogenic stimuli again underlining that 
osteoblasts had successfully been generated as described before (zur Nieden et al., 
2003).  
   
 
 
 
5.2 The miRNA expression profile of ESCs differentiated into osteoblasts for 8 
days 
After it had been confirmed that osteoblasts could be generated with the chosen 
method and cell line, a miRNA profiling study was performed in order to identify 
lineage committing miRNAs. Indeed, miRNA profiling is a reliable method to identify 
miRNAs which are differentially expressed in a state of interest.  Therefore, through 
the determination of the cell specific miRNA profile, it is possible to identify genes 
whose expression must be restricted when cellular states change, such as during 
osteogenic differentiation. To explore the potential variation of miRNA expression 
levels during the course of ESCs differentiation towards osteoblasts, their expression 
profiles were determined with mouse specific miRNA microarrays in collaboration 
with Dr. Joerg Hackermueller (Fraunhofer IZI) in the first eight days of osteogenic 
differentiation, which is when lineage commitment occurs. Total RNA enriched for 
miRNAs extracted from undifferentiated and differentiated ESCs was used to 
generate changes in miRNA expression profiles. 
 
GAPDH 
OCN 
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T-Bra 
Figure 7. Expression of T-Bra and OCN 
during the time course of osteogenic 
differentiation. T-Bra and OCN mRNA levels 
were detected with semi-quantitative RT-PCR 
from cells cultured in osteoblast promoting 
medium. GAPDH was utilized as a 
housekeeping gene in PCR conditions 
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5.2.1 Quality control of samples used for the array:  
5.2.1.1 RNA integrity check 
RNA samples required for array analysis were checked for their quality prior to 
running any experiments. To estimate the quality of RNA, the Agilent BioAnalyzer 
was used as described in section 4.3.3 and RNA integrity numbers (RINs) were 
assessed (Fig. 8). RNA samples were only used for array studies when they had a 
RIN above 8 to ensure that no degradation had occurred, which could have skewed 
the results. The Agilent BioAnalyzer analysis showed that RNA molecules smaller 
then 150 nt were present in all samples. The prominent ribosomal RNA bands, 18S 
and 28S, were also clearly visible in all samples. 
 
 
5.2.1.2 Validation of pluripotency and differentiation markers in samples used for 
miRNA arrays 
The pluripotent state and self-renewing ability of ESCs are maintained by the 
transcriptional factor Oct-4 (Niwa et al., 2000). A critical amount of Oct-4 expression 
is required to sustain stem-cell pluripotency and this marker is down-regulated as 
cells differentiate in vitro and in vivo (Niwa et al., 2000; Pesce et al., 2001). It has 
been already shown by assaying markers of germ layers that ESCs are able to 
differentiate into a variety of cell types. However, no single marker is sufficient or 
unique for verifying early osteogenic differentiation. Thus, based on published data at 
the level of gene expression, an optimal combination of markers expressed by 
progenitors with osteogenic capability has been chosen, such as T-Bra, 
neurofilament protein (NF-68), p75 neurotrophin receptor (p75) and oncofetal antigen 
expression (5T4) (Fig. 9). T-Bra plays a key role in the establishment and elaboration 
of the mesoderm (Smith et al., 1991), while neural crest stem cells have been 
isolated based on their surface expression of p75 (Stemple et al., 1992; Morrison et 
al., 1999). NF-68 is the earliest marker highly expressed during neuronal 
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Figure 8. Electropherogram check of total 
RNA. Results showed no degradation of RNA 
isolated from undifferentiated and differentiated 
cells.  
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differentiation (Tropepe et al., 2001). In addition, it has been shown that kinetics of 
5T4, a motility factor, is up-regulated in ESCs following removal of LIF (King et al., 
1999) and therefore it represents a general differentiation marker.  
While the ESC line chosen gave a robust osteoblast output, valid lineage committing 
miRNAs can only be identified if the early differentiation in samples selected for the 
array also follows a known pattern. In order to confirm whether the early 
differentiation followed the pattern that had been previously observed, RNA and 
miRNA samples were harvested from the same samples. The RNA samples were 
used to synthesize cDNA, which then in turn was examined by RT-PCR to asses the 
expression levels of Oct-4, T-Bra, NF-68, p75 and 5T4. The expression patterns of all 
these genes were screened at day 0, 3, 5, 6 and 8. As expected, the level of Oct-4 
transcript was down-regulated following differentiation. On the other hand the levels 
of T-Bra, NF-68 and 5T4 were elevated (Fig. 9). The expression of T-Bra and 5T4 
genes were dramatically increased on day 5 and gradually decreased during 
osteogenic differentiation. However, NF-68 appeared to be highly expresses on day 
6 of differentiation. In addition, p75 mRNA expression seemed to be up-regulated 
upon VD3 treatment in osteogenic cultures, potentially suggesting that osteogenic 
induction occurs from a neural crest origin.  
 
 
 
5.3 miRNA expression profiling 
5.3.1 Comparison between undifferentiated and differentiated ESCs 
To identify miRNAs that are potentially involved in osteogenic differentiation, miRNA 
expression profiling was performed. Before subjected to an oligonucleotide-based 
microarray, RNA samples were collected from undifferentiated ESCs and during a 
time-course of VD3-induced osteogenic differentiation, as described in section 4.3.2. 
Based on the fact that previous experiments confirmed the integrity of the used RNA 
Oct-4  
T-Bra  
GAPDH 
NF-68 
p75  
5T4  
c      VD3     c      VD3   
           0        3        5            6                  8             Day    
Figure 9. RT-PCR of key marker genes 
involved in maintenance of pluripotency 
and differentiation. Oct-4 is a marker of ESCs 
pluripotency. T-Bra and NF-68 are markers of 
early mesodermal and ectodermal 
differentiation, respectively. While p75 is a 
neural crest marker, 5T4 is a marker of general 
differentiation. GAPDH was used as a 
housekeeping gene. 
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to be excellent and that the differentiation had followed expected patterns in a small 
subset of mRNAs, the miRNA population was then isolated from the total RNA 
samples (see section 4.3.2). Then, miRNA samples were labeled and hybridized to 
Combimatrix 4x2K miRNA microarrays (see section 4.4).  
Given the phasic nature of osteogenesis the expression analysis of miRNAs were 
made as the comparison between undifferentiated and differentiated state, including 
day 6 and 8 between spontaneous and osteogenic differentiation state (Fig. 6). Of 
particular interest were miRNAs that were induced within the 6d and 8d of osteogenic 
differentiation. During this period of time, there was an increase in number of 
proliferating osteoblast progenitor cells. Moreover, Wnt signaling is observed to 
switch around 6-8d of VD3 treatment cultures in concert with an increase of OPN and 
Col I expression (zur Nieden et al., 2003). The microarray data, indeed, indicated that 
there were significant changes in the miRNA expression during this early osteogenic 
differentiation of ESCs. Twenty five of nearly 250 miRNAs showed differential 
expression between undifferentiated and differentiated ESCs. Moreover, during 
differentiation many miRNAs were expressed at low levels and the down-regulation 
of miRNAs appeared to be common in the osteogenically induced ESCs (Fig. 10). 
The minimum intensity threshold criterion was subjected for this microarray 
expression data. miRNAs were considered expressed if their normalized log fold 
change (logFC) intensity was >1 or -1 in at least one time point. Tables 1-6 show the 
log FC of mouse miRNAs at various time points (see section 9.1). In many cases, it 
has been observed that related miRNAs, for example miRNAs expressed in a 
polycistronic cluster, showed similar expression profiles. Indeed, miR-290 family 
members, miR-291a-5p, miR-291b-5p and miR-293, were found to be strongly up-
regulated in ESCs and down-regulated during differentiation (Fig. 10, see section 
9.1). Similarly, miR-127, miR-300 and miR-495, which are located on chromosome 
12, were down-regulated during spontaneous and osteogenic differentiation (Fig. 10, 
Tab.1-6, section 9.1). All of miRNAs in these clusters passed the significance and FC 
thresholds. The observed decreasing trend in the number of miRNAs with logFC 
intensity >-1 through the differentiation process and the numerous examples of 
miRNAs with low intensity values that show agreement in expression profiles with 
other cluster members, demonstrate the ability of the microarray to detect differences 
at low intensity.  
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Figure 10. Heat map of differentially expressed miRNAs between differentiated and 
undifferentiated ESCs.  miRNAs were isolated from the differentiated and undifferentiated ESCs and 
their expressions were analyzed using Combimatrix 4x2k mouse miRNA microarrays. The heat map 
plot shows microarray expression data for those miRNAs that were found to be differentially expressed 
between the undifferentiated and differentiated ESCs at a p< 0.05. Hierarchical clustering is based on 
miRNA expression. Red and blue indicate low and high expression, respectively. Individual p-values 
are given in Tab 1-6 (see section 9.1). 
 
5.3.2 Validation of array data 
Microarrays can sometimes give false positive results. For example, discrimination 
between miRNAs of the same family that differ in one nucleotide only, is often 
impossible. To validate the array data, the expression of four miRNAs was analyzed 
using reverse transcription quantitative PCR (RT-qPCR) with miRNA specific 
TaqMan assays (see section 4.3.6). For validation, those miRNAs that were highly 
differentially expressed on day 3 of differentiation were selected. As a normalization 
control, expression levels of the sno202 RNA were measured. The results were 
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confirmed for all miRNAs analyzed and comparable reconstitution of miRNA 
expression to microarray data verified (Fig. 11). 
 
 
Figure 11. Comparison between RT-qPCR and microarray results for miR-183, miR-361, miR-
665 and miR-690. Microarray data analysis was validated using specific stem loop primers. 
Measurements were done in triplicates and normalized to signal obtained from sno202.  
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5.4 Effect of miRNA overexpression on undifferentiated ESCs  
miRNA profiling is an important tool for the identification of differentially expressed 
miRNAs in normal cellular and disease processes. However, this method cannot 
predict if miRNA is of functional relevance in the state or process. Therefore, 
functional studies, as well as target identification is necessary in order to prove that 
distinct miRNA contributes to the present conditions. To understand the possible role 
of miRNAs, a pSuper vector system described by Brummelkamp et al. 
(Brummelkamp et al., 2002) was applied to overexpress miR-22, miR-127, miR-130a, 
miR-183, miR-291b-5p, miR-293, miR-300, miR-361, miR-467b, miR-665 and miR-
690 in undifferentiated ESCs. As a control, miR-scr, a random sequence of 19 nt 
length that is expressed and processed like a real miRNA was used. 
 
5.4.1 Generation of miRNA expression vectors 
In order to test the functionality of miRNA candidates in undifferentiated ESCs and 
during osteogenic differentiation overexpression of miRNAs were used as an 
approach. The specific oligonucleotides containing their sequences were first cloned 
into the pSuper.neo vector. The 60-70 bp forward and reverse oligonucleotides were 
annealed and cloned between the Bgl II and Hind III enzyme recognition sites. 
Plasmid was prepared and digested as described in section 4.2.4 and 4.2.5, 
respectively. Successful cloning was confirmed by PCR colony assay. The obtained 
colonies from transformations were used as DNA templates in a standard PCR 
protocol (see section 4.3.5). Primers used in the assay were designed to identify the 
clones of pSuper.neo vector and their sequences are outlined in section 3.6.2. The 
PCR fragments of 290 bp, containing miRNA candidate sequence are shown in Fig. 
12, while the empty vector gave an amplicon at 227 bp. 
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Figure 12. PCR screen for pSuper.neo clones generated. Gel electrophoresis showing PCR colony 
products. Line 1: 1kb ladder, Line 2: fragment of 227 bp, empty pSuper.neo vector, Line 3-12: 
fragments of approximately 290 bp containing miRNA sequence. 
 
5.4.2 Validation of miRNA overexpression in ESCs  
To validate overexpression of miRNAs in undifferentiated ESCs, miR-293, miR-361, 
miR-665 and miR-690 expression was analyzed using RT-qPCR 24h and 48h after 
transfection (see section 4.3.6.1) (Fig. 13). The sno202 RNA was measured as a 
normalization control. Overexpression of miRNAs was verified and resulted in high 
expression level of miRNAs 24h after transfection. 
 
Figure 13. Relative efficiency of miRNA overexpression in ESCs. ESCs were transfected with the 
pSuper miRNA expression vector using Effectene transfection reagent. Total RNA was isolated 24h 
and 48h post-transfection and miRNA expression was analyzed by RT-qPCR using miRNA-specific 
TaqMan Assay. Results are expressed as mean ± SD, (n=3) and normalized to signal obtained from 
sno202.  
 
5.4.3 miRNA overexpression induces changes in cell survival 
It has been reported that miRNAs play an essential role in stem cell self-renewal and 
differentiation by negatively regulating the expression of certain key genes involved 
in cell survival (Hatfield et al., 2008). Therefore, the cell viability upon miRNA 
overexpression was investigated by employing the MTT assay. Candidate miRNAs 
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were overexpressed by using pSuper miRNA expression vector according to chapter 
3.8.1 and 4.1.9. Viability of mouse ESCs was evaluated 24h and 48h after 
transfection. Relative cell viability (percent) for each sample was determined as a 
ratio of average absorbance for cells transfected with miR-scr to that for cells 
overexpressing miRNAs. An assessment of the MTT assay demonstrated that 
reduction of ESC viability was miRNA dependent. As shown on Fig. 14, there were 
no statistically significant differences after 24h between the viability rate in cells 
overexpressing miRNAs and those transfected with miR-scr. However, after 48h 
post-transfection, miR-300, miR-361, miR-477b and miR-665 significantly decreased 
the survival of ESCs. Cell survival was inhibited to a greater extent (p<0.05) in case 
of miR-361 overexpression and only 38% of cells were metabolically active compared 
to the miR-scr transfected cells (Fig.14). 
 
Figure 14. miRNA overexpression impaired ESC survival. ESCs were transfected with candidate 
of miRNA expression vectors and cell viability was assessed 24h and 48h after transfection. Results 
are expressed as mean ±SD (n=3) and normalized to miR-scr expressed cells. Significant differences 
were apparent (* p<0.05).  
 
5.5 Effect of miRNA overexpression on ESCs differentiated into osteoblasts 
5.5.1 Validation of miRNA overexpression in differentiating ESCs 
While these previous studies had confirmed a role for some miRNA candidates in 
undifferentiated ESCs, effects of miRNA gain-of-function on differentiating ESCs also 
had to be evaluated. Therefore, the respective miRNA expression vectors were 
applied in transfections to enhance the expression of miR-361 and miR-665 while 
ESCs were differentiating. ESCs were transfected once, on day 0 with miRNA 
encoding plasmids and differentiated for 5 days (see section 4.1.9). To verify 
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overexpression of miRNA before the osteogenic yield was evaluated, miRNA levels 
were analyzed on differentiating day 1, 3 and 5 using TaqMan microRNA quantitative 
real-time stem-loop PCR assays (see section 4.3.6). The sno202 RNA was 
measured as a normalization control. Enhanced miRNA expression was observable 
48h post-transfection (1 day of differentiation), and became less pronounced the 
following days of differentiation (Fig. 15). To keep the miRNA expression levels 
increased, the ESCs were additionally transfected during following days of 
differentiation (see section 4.1.9). 
 
Figure 15.   Relative efficiency of miRNA overexpression during differentiation. ESCs were 
transfected with pSuper.neo miRNA constructs using Effectene transfection reagent. Total RNA was 
isolated on day 1, 3 and 5 of differentiation, post-transfection. miRNA expression was analyzed by RT-
qPCR using a miRNA-specific TaqMan Assay. Results are expressed as mean ±SD (n=3) and 
normalized to signal obtained from sno202.  
 
5.5.2 miRNA overexpression affects osteoblast yield 
5.5.2.1 Mineralization 
Knowing that the effect of the overexpression lasted only for a limited time, miR-scr 
miR-22, miR-127, miR-130a, miR-183, miR-291b-5p, miR-293, miR-300, miR-361, 
miR-467b, miR-665 and miR-690 were overexpressed on day 0, 5 and 10 of 
spontaneous and osteogenic differentiation in all subsequent experiments and 
osteogenic output measured with a variety of methods (Fig. 16). First, the effect of 
miRNA expression on the phenotype of the cultures was analyzed on day 30 of 
spontaneous and osteogenic differentiation. Overexpression of miRNA candidates 
except miR-690 induced changes during osteogenic differentiation, whereas no effect 
was detectable during spontaneous differentiation and miR-scr transfection. As seen 
in Fig. 16, the strongest mineralization was observed after overexpression of miR-22 
and miR-361. While enhanced levels of miR-127, miR-300 and miR-665, miRNAs 
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encoded in chromosome 12, visibly decreased number of osteoblast compared with 
miR-scr transfected cells. On the other hand, the cytotoxic effect of miR-130a and 
miR-183 was seen during differentiation. Although most ESCs cultures transfected 
with these miRNAs were strongly mineralized the growth and the viability of cells 
decreased dramatically. Moreover, interestingly, overexpression of mir-291b-5p, miR-
293 and miR-467b, miRNAs of cluster 7, affected with migration of mineralized cells. 
 
 
Figure 16. The effect of miRNAs overexpression on spontaneous and osteogenic 
differentiation. ESCs were transfected with miRNA encoding plasmids and cultured in control and 
osteogenic medium. Mineralization can be recognized as black coloration in phase contrast 
microscopy. Pictures were taken at day 30 of differentiation. Scale bar represents 500µm. 
 
In an attempt to determinate whether the overexpression of miRNAs could influence 
osteogenic differentiation, the calcium deposition and ALP activity assays were also 
performed. The amount of deposited calcium as well as ALP activity were measured 
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at day 30 of spontaneous and osteogenic differentiation and normalized to the total 
protein content (see sections 4.1.6, 4.1.7). Calcium content and ALP activity in 
miRNA+ cells were always compared to measurements found for miR-scr and 
spontaneous cultures. As shown in Fig. 17A, the amount of calcium was significantly 
increased in cells cultured in osteogenic medium and expressing miR-361 (p<0.05). 
In contrast, expression of miR-183 and miR-291b-5p induced a significant decrease 
of the amount of calcium (p<0.05). Similarly, ALP activity was markedly elevated in 
miR-361+ ESCs and incubated in osteogenic medium, as shown in Fig. 17B.  
 
 
 
 
 
Figure 17. The effect of miRNAs overexpression on calcium deposition and ALP activity. Mean 
calcium content (A) and mean ALP activity (B) during spontaneous and osteogenic differentiation of 
ESCs upon miRNAs overexpression. Data are reported as a mean ± SD (n=3). Significant differences 
were apparent (* p<0.05). 
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5.5.2.2 MiRNA overexpression affects OCN, BSP and Cbfα-1 expression  
To demonstrate that miRNA overexpression might impair osteogenic differentiation, 
OCN expression level was assessed by RT-PCR on day 30 of differentiation. The 
levels of OCN in spontaneously and VD3, βGP, AA induced cells were generally 
higher compared to miR-scr expressed cells, except miR-690 in spontaneous 
cultures and miR-130a, miR-665, miR-690 in osteogenic cultures. Moreover, 
overexpression of miR-127, miR-183, miR-293, miR-300, miR-361 and miR-467b 
during osteogenic differentiation evidently induced an increase in OCN levels (Fig. 
18). 
 
 
In addition to RT-PCR, the effect of miR-361 overexpression on OCN, BSP and 
Cbfα-1 mRNA levels were quantitatively assessed using qPCR. Analysis revealed 
that miR-361 expression may contribute to the increase of all three osteogenic 
markers (Fig. 19). 
 
Figure 19. Expression of OCN, BSP and Cbfα-1 during spontaneous and osteogenic 
differentiation of ESCs after miR-361 overexpression. ESCs were transfected with a miR-361 
expression vector and differentiated toward osteoblasts. Total RNA was isolated on day 30 of 
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Figure 18. Expression of OCN 
during spontaneous and 
osteogenic differentiation after 
miRNA overexpression. ESCs 
were transfected with miRNA 
expression vectors and 
differentiated spontaneously and 
into osteoblasts. RNA was 
extracted, reverse transcribed and 
PCR amplification of OCN and 
GAPDH were performed 
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differentiation and OCN, BSP and Cbfa-1 expression were analyzed by RT-qPCR. Results are 
expressed as mean ±SD, (n=3) and normalized to signal obtained from GAPDH.  
 
5.6 Effect of miRNA knockdown on ESCs during osteogenic differentiation 
5.6.1 Validation of miRNA knockdown in differentiating ESCs 
Temporal inhibition of miRNAs by antisense molecules provides another strategy to 
study miRNA function. 2′-O-methyl oligonucleotides have been successfully used in 
vitro and in vivo to knockdown miRNAs (Hutvagner et al., 2004; Meister et al., 2004; 
Krutzfeldt et al., 2005). Many publications exist, showing that miRNA knockdown 
strongly impacts differentiation. Therefore, loss-of-function studies have to prove that 
distinct miRNAs contribute to the present conditions. Hence, LNA modified miRNAs 
were applied to knockdown the expression of miR-361 and miR-665 in ESCs 
differentiating into osteoblasts. To validate the inhibition of miRNA expression, 
miRNA levels were analyzed using qPCR on day 1, 3 and 5 of differentiation, post-
transfection. The expression of sno202 RNA was measured as a normalization 
control. Knockdown of miR-665 expression was observable on day 1 of 
differentiation, and became less pronounced the following days of differentiation. 
However, the effect of miR-361 inhibition was detectable only after 3d (Fig 20). 
 
Figure 20. Relative efficiency of miRNA knockdown during osteogenic differentiation. ESCs 
were transfected with LNA modified miRNAs using Effectene transfection reagent. Total RNA was 
isolated on day 1, 3 and 5 of differentiation, post-transfection and miRNA expression was analyzed 
with qPCR using a miRNA-specific TaqMan Assay. Results are expressed as mean ± SD, (n=3) and 
normalized to signal obtained from sno202.  
 
5.6.2 miRNA knockdown affects osteoblast yield 
5.6.2.1 Mineralization 
To demonstrate the role of miRNAs during osteogenic differentiation, miR-183, miR-
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spontaneous and osteogenic differentiation. The effect of miRNA inhibition on cell 
morphology was analyzed on day 30 of spontaneous and osteogenic differentiation 
(Fig. 21). Knockdown of all miRNA candidates induced changes during osteogenic 
differentiation, whereas no effect was detectable during spontaneous differentiation 
and after miR-scr transfection. The strongest mineralization was observed in the 
inhibition of miR-665 (Fig. 21). In contrast, knockdown of miR-183, miR-293 and miR-
361 visibly decreased the number of osteoblasts compared with miR-scr transfected 
cells (Fig. 21). 
 
Figure 21. The effect of miRNA knockdown on spontaneous and osteogenic differentiation. 
Mineralization can be recognized as black coloration in phase contrast microscopy. ESCs were 
transfected with miRNA encoding plasmids and cultured in control and osteogenic medium. Pictures 
were collected at day 30 of differentiation. Scale bar represents 500µm. 
 
It has been shown in section 5.5.2 that overexpression of miRNAs can influence 
calcium deposition and ALP activity. Therefore, we also investigated the effect of 
miRNA knockdown on osteogenic differentiation. Calcium amount and ALP activity 
during spontaneous and osteogenic differentiation of ESCs were assessed at day 30 
and samples were normalized to total protein content and were compared to miR-scr 
and spontaneous cultures. As shown in Fig. 22A, the amount of calcium was 
increased significantly (p<0.05) in cells differentiated into osteoblasts when miR-665 
was knocked down. ALP activity was markedly elevated in ESCs expressing miR-293 
and miR-690 (p<0.05). Furthermore, knockdown of miR-665 led to a greater increase 
in (p<0.001) ALP activity during osteogenic differentiation (Fig. 22 B).  
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Figure 22. The effect of miRNA knockdown on calcium deposition and ALP activity. Mean 
calcium content (A) and mean ALP activity (B) during spontaneous and osteogenic differentiation of 
ESCs upon miRNAs inhibition. Significant differences were apparent (*, p<0.05 and **p<0.001) 
 
5.6.2.2 miRNA knockdown affects OCN expression  
To prove if miRNA knockdown might impact the expression of OCN, a semi- 
quantitative PCR was performed at day 30 of spontaneous and osteogenic 
differentiation. The levels of OCN in spontaneously differentiating and osteogenically 
induced cells were generally higher compared to cells expressing miR-scr, except for 
miR-361 in spontaneous and miR-690 in osteogenic cultures. However, knockdown 
of miR-183 and miR-665 in osteogenic conditions evidently induced an increase in 
OCN levels (Fig. 23). 
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Figure 23. Expression of OCN during 
spontaneous and osteogenic differentiation 
of ESCs upon miRNA knockdown. ESCs were 
transfected with LNA modified miRNAs and 
induced to differentiate spontaneously and into 
osteoblasts. RNA was extracted, reverse 
transcribed and PCR amplification of OCN and 
GAPDH was performed 
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5.7 Target identification 
Identifying the downstream targets of miRNAs involved in osteoblast differentiation is 
important to understand cellular regulatory networks. In essence, the collected data 
so far indicated that some of the candidate miRNAs modulated osteoblast 
differentiation by effecting cell survival, cell morphology, the amount of calcium that is 
deposited, ALP activity and expression of osteogenic markers. In the next step, the 
mRNA targets of the identified miRNAs should be characterized. In order to do so, 
three different approaches were combined: bioinformatic target prediction, mRNA 
expression analysis and TurboGFP reduction utilizing the p2FP-RNAi vector to trace 
RNA interference upon miRNA overexpression (see section 3.8.1). 
 
5.7.1 Bioinformatic target prediction 
Target predictions were obtained from two published miRNA target gene prediction 
databases: TargetScan (Lewis et al., 2005) and miRBase Targets (Griffiths-Jones et 
al., 2006). Using miRBase Targets source, 977 target hits were found for miR-183, 
877 hits for miR-293, 810 for miR-361, 870 hits for miR-665 and 799 hits for miR-690. 
A PubMed based literature search showed that a number of these target candidates 
appeared to be important members of the Wnt signaling cascade.  
 
5.7.2 mRNA expression analysis upon miRNA overexpression reveals target 
mRNAs associated with osteogenic lineage development 
Each miRNA can regulate numerous target genes and therefore has the potential to 
modulate a single signaling pathway at multiple different levels. To explore which 
target candidate might be regulated by a specific miRNA, target mRNA expression 
was studied in response to overexpression of miR-scr, miR-183, miR-293, miR-361, 
miR-665 and miR-690 using RT-qPCR. The rational for using this method is that the 
binding of a given miRNA to its specific mRNA target site will repress mRNA 
expression. The target mRNA degradation by miRNA was reflected in reduction of its 
expression levels.  
ESCs were transfected with pSuper.neo constructs and RNA was harvested 24h and 
48h post-transfection. Quantitative PCR was performed as described in section 4.3.6 
with levels in miR-scr serving as control. To confirm that the post-transcriptional 
suppression of mRNA expression was indeed due to the overexpressed miRNA the 
target mRNA levels were assessed 24h and 48h after transfection. To be mentioned, 
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most mRNA down-regulations at 48h are likely to be indirect effects of miRNA 
overexpression. Thus, secondary regulations are usually considered to happen later 
than 24h after miRNA transfection (Tu et al., 2009). Therefore, it has been postulated 
that miRNAs are fast molecular switches of gene expression and their response 
seem to have a time lag (Hammell et al., 2008). In order to identify miRNA target 
candidates involved in osteogenic differentiation, the Wnt signaling modulators were 
considered in further analysis. miR-183 and miR-690 were predicted to target, among 
other genes, forkhead box O 3a (FoxO-3a). It has been identified that FoxO 
transcription factors are interaction partners of CatnB (Essers et al., 2005). In the Wnt 
pathway, FoxO-3 competes with TCF for interaction with CatnB thereby inhibiting 
TCF transcriptional activity (Hoogeboom et al., 2008). In this study, decreased levels 
of FoxO-3a expression 24h and 48h post-transfection were observed only upon miR-
690 overexpression (Fig. 28). However, neither FoxO-3a nor LRP-5/6 expression 
levels were repressed upon overexpression of miR-183 (Fig. 24). 
 
 
 
WIF-1, Dikkoppf 1 (Dkk-1) and paired-like homeodomain transcription factor 2 (PITX-
2) were predicted to be potential targets of miR-293. In this study, miR-293 
decreased only WIF-1 mRNA levels 24h and 48h post transfection (Fig. 25). WIF-1 
belongs to the members of secreted modulators of Wnt proteins. It has been shown 
that treatment with WIF-1 of mesenchymal cells during osteogenic differentiation 
significantly reduces ALP activity. Thus, WIF-1 is a negative regulator of osteoblast 
differentiation (Cho et al., 2009).  
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Figure 24. Validation of FoxO-3a and 
LRP-5/6 levels upon miR-183 
overexpression in ESCs. RT-qPCR 
measured mRNA levels of FoxO-3a and 
LRP-5/6 in ESCs. Expression levels, 
including those of miR-scr are assessed as 
FC relative to a housekeeping gene 
(GAPDH). Data are the means of three 
independent cell culture experiments. 
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Figure 25. Repression of WIF-1 mRNA level by miR-293. WIF-1, Dkk-1 and PITX-2 mRNA 
expression was measured by RT-qPCR. Overexpression of miRNA contributes to a decrease in 
predicted target levels. Expression levels, including those of miR-scr are assessed as fold change 
relative to a housekeeping gene (GAPDH). Data are the means of three independent cell culture 
experiments. 
 
miR-361 was able to repress nuclear factor of activated T-cells 3 (NFATc-3) and 
Prickle-1 expression 24h and 48h and 24h post-transfection, respectively (Fig. 26). 
NFATc-3-calcineurin signaling is an important calcium sensitive pathway controlling 
bone formation. Furthermore, it has been speculated that Wnt5a and NFATc might 
be parallelly acting pathways so they could exhibit an additive effect. NFATc 
activation is sufficient but no necessary in mediating Wnt5a-induced-CatnB 
degradation, which may imply that Wnt5a signals through the combined effect of 
NFATc activation in promoting CatnB degradation (Topol et al., 2003). Prickle-1 is 
able to regulate Wnt signaling by interaction with Dvl-3 (Chan et al., 2006). A 
potential function of Prickle-1 during osteogenic differentiation is described in section 
6.4.1 
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Figure 26. Repression of Prickle-1 
mRNA level by miR-361. NFATc-3, 
Prickle-1 and Fzd-3 mRNA levels were 
validated by qPCR upon miR-361 
overexpression in ESCs. Expression 
levels, including those of miR-scr are 
assessed as fold change relative to a 
housekeeping gene (GAPDH). Data 
are the means of three independent 
cell culture experiments. 
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miR-665 was predicted to target Wnt8a and Dvl-1. Dvl-1 is a cytoplasmic 
phosphoprotein involved in the Wnt signaling, which has been shown to play a role in 
regulating osteoblast differentiation (Zhong et al., 2006). Decreased levels of Dvl-1 
mRNA 24h and 48h post-transfection were observed after miR-665 overexpression 
(Fig. 27).  
 
 
In this study, decreased levels of FoxO-3a (see above), Ras homolog gene family, 
member A (RhoA) and CatnB-1 were exhibited 24h post-transfection in response to 
the miR-690 overexpression (Fig. 28). RhoA GTPases play a significant role in 
regulating cytoskeletal dynamics and have been shown to be crucial for cell 
proliferation and differentiation. Specifically, progenitor cells with constitutively active 
RhoA are able to undergo osteogenic differentiation (McBeath et al., 2004). The role 
of CatnB, as an important component of Wnt signaling is described in section 1.3.2. 
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Figure 27. Overexpression of miR-665 
suppresses Dvl-1 mRNA expression. 
Wnt8a and Dvl-1 mRNA levels were 
measured by RT-qPCR upon miR-665 
overexpression in ESCs. Expression 
levels, including those of miR-scr are 
assessed as fold change relative to a 
housekeeping gene (GAPDH). Data are 
the means of three independent cell culture 
experiments. 
 
Figure 28. FoxO-3a, RhoA and 
CatnB-1 mRNA expression 
were suppressed upon the 
miR-690 overexpression. 
QPCR verification of FoxO-3a, 
Wnt8a, RhoA and CatnB-1 levels 
upon miR-690 overexpression in 
ESCs. Expression levels, 
including those of miR-scr are 
assessed as fold change relative 
to a housekeeping gene 
(GAPDH). Data are the means of 
three independent cell culture 
experiments. 
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Taken together, in this study, decreased levels of mRNA expression 24h post-
transfection were observed in transcripts for WIF-1 which was regulated by miR-293, 
for NFATc-3 and Prickle-1 by miR-361, for Dvl-1 by miR-665 and for FoxO-3a, RhoA 
and CatnB-1 by miR-690.   
 
5.7.3 Direct target identification using the p2FP-RNAi vector  
Comparing the two different target identification methods, bioinformatic predictions 
and total mRNA analysis upon miRNA overexpression, only few target candidates 
could be identified. It is clear from this mRNA expression/miRNA overexpression data 
that down-regulated mRNA transcripts for WIF-1, NFATc-3, Prickle-1, Dvl-1, FoxO-
3a, RhoA and CatnB-1 are potentially direct targets of these miRNAs. Additionally, it 
has been shown previously that miR-361 overexpression significantly affects 
osteogenic differentiation. Therefore, specifically, NFATc-3 and Prickle-1 were 
chosen for further investigation as targets for miR-361. In an attempt to validate 
mRNA/miRNA interactions, the p2FP-RNAi vector system was applied, which is 
explained under section 4.2.12. This method exhibits a greater sensitivity with the 
examination of such interactions. The rational for using this assay was that the 
binding of a given miRNA to its specific mRNA target site will repress TurboGFP 
production thereby reducing GFP expression that can be measured and compared to 
a control. The experimental approach was to clone the 3’UTR of the target gene of 
NFATc-3 and Prickle-1 immediately downstream of the TurboGFP open reading 
frame sequence. 3’UTR fragments of a selected mRNA were generated by PCR 
amplification using primers denoted in section 3.6.2. Fragments of the expected size 
were found for all PCR reactions as shown in Fig. 29A. Before the actual cloning 
procedure, amplicons of the correct size were taken through a verification of 
amplicon identity using restriction analysis (see section 4.2.5).  Specifically, Hind III 
was used for Prickle-1, EcoR I for secreted frizzled-related protein 4 (SFRP-4) and 
RhoA, Pst I for FoxO-3a and Bgl II for WIF-1 (Fig. 29B). In combination with 
bioinformatic sequence analysis, these restriction reactions confirmed that fragments 
specific for the 3'UTR region of the mRNA candidates had been generated. In a next 
step, these fragments were ligated into the p2FP-RNAi plasmid, previously digested 
with Bgl II and Sal I (see section 4.2.8). The ligation products were transformed into 
DH5α competent cells using a heat shock method (see section 4.2.3). Plasmid 
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preparation was performed on the resulting colonies and the presence of insert was 
confirmed with Bgl II and Sal I digestion (see section 4.2.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. PCR screen for generated p2FP-RNAi clones. Ethidium bromide stained gel pictures for: 
A. 3’UTR PCR fragments. Line M: 1kb ladder, Line 1: NFATc-3, fragment of 1.6kb, Line 2: Prickle-1, 
fragment of 1.3kb, Line3: SFRP-4, fragment of 0.4, Line 4: FoxO-3, fragment of 0.5kb, Line 5: RhoA, 
fragment of 0.4kb, Line 6: CatnB-1, fragment of 0.4kb,  Line 6: Dkk-1, fragment of 0.5kb, Line 7: WIF-
1, fragment of 0.9kb, Line 8: LRP5/6, fragment of 0.3kb,  B. endonuclease digestion of  selected 
3’UTR fragments.  
 
While clones had been generated for Prickle-1, NFATc-3, direct targets were only 
confirmed for miR-361 in the next step. To make use of the p2FP-RNAi vector 
system, HeLa cells were co-transfected with the respective p2FP-RNAi and the 
miRNA pSuper.neo expression vectors (see section 4.1.10). Scramble pSuper.neo 
was used as control. With the technique chosen, transfection efficiency as judged by 
the appearance of red fluorescing cells was generally very high, but somewhat 
variable (Fig. 30 and 31). The effect of miRNA expression on TurboGFP intensity 
was then analyzed 48h post-transfection by estimating the number of TurboGFP, 
JRed and both TurboGFP and JRed-positive cells using flow cytometry. Since the 
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transfection efficiency varied, the number of TurboGFP positive cells was normalized 
to JRed fluorescence. As expected, the expression of miR-scr had no influence on 
TurboGFP intensity. The transfection with pSuper-miR-361 construct resulted in 
repression of Prickle-1 and NFATc-3 (Fig. 30). However, a more pronounced 
decrease was observed with the Prickle-1, approximately 40% less TurboGFP 
expression compared to control cells transfected with miR-scr vector (Fig. 30 & 31).  
 
Figure 30. miR-361 reduces Prickle-1 levels. Fluorescent microscopy images of HeLa cells which 
were co-transfected with p2FP-RNAi vectors containing the 3’UTR regions of Prickle-1 and NFATc-3 
and miR-scr, miR-361 expression vectors, respectively. JRed served as a positive transfection marker 
while TurboGFP stands as an inducer of gene silencing efficiency. Scale bar represents 100µm. 
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Figure 31. miR-361 reduces Prickle-1 and 
NFATc-3 levels.  FACS analysis of Prickle-1 
and NFATc-3 expression levels upon miR-
scr and miR-361 overexpression 48h after 
transfection. Results are expressed as mean 
±SD, (n=3) and normalized to signal 
obtained from JRed. 
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6. Discussion 
It is clear that gene expression is precisely controlled in a cell-, tissue-, time-, and 
condition-specific manner. Large-scale microarray profiling studies have suggested 
that different cells, tissues, and organ systems within an organism have different gene 
expression profiles, although they have the same genome. Moreover, these gene 
expression signatures are sensitive to changes in condition, such as development, 
diseases, environment changes, and therapeutic drugs (Birchler et al., 2007; 
Rajewsky et al., 2006). Therefore, completely understanding the regulatory 
mechanisms of gene expression is one of the most important issues. Any important 
breakthrough in the area of gene regulation will have the potential to impact clinical 
medicine. 
During the last years miRNAs have become a widely studied field of molecular 
biology and as a result many miRNAs have been identified that are associated with 
embryonic development and cell differentiation. Several studies have identified 
populations of miRNAs that are associated with specific stem cell types or those that 
are regulated during stem cell differentiation. However, the regulatory mechanism of 
miRNAs in osteoblast proliferation and differentiation from stem cells has been poorly 
defined so far. Therefore, identification of such osteogenic miRNAs in stem cells in 
vitro may be used to enhance the generation of stem cell-derived osteoblasts for cell 
replacement therapies. 
In the current study, global miRNA profiling of ESCs that were differentiated towards 
osteoblasts was used to identify miRNAs that govern the process of osteogenesis. 
miRNA profiling during the proliferation stage and mesendodermal commitment (day 
3, 5, 6 and 8 of differentiation) showed up- and down-regulation of miRNAs. 
Moreover, miRNA profiling data are consistent with recently published studies in 
which miR-291a-3p, miR-291a-5p and miR-293 were shown to be expressed in 
pluripotent undifferentiated ESCs. Using three different target identification 
approaches, most targets were found to be associated with embryonic development 
and bone formation, particularly by modulating the Wnt signalling pathways. Gain-of-
function and loss-of-function analysis indicated that miR-361 acts as an activator and 
miR-665 as a suppressor of osteogenic differentiation by downstream modulation of 
Wnt signalling.  
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6.1 Methodical strategy and technical issues 
A number of different approaches to quantifying miRNAs have been described so far, 
including microarrays, modified invader assay, bead-based flow cytometry assay and 
real-time PCR (Slaby et al., 2009). miRNA microarray, the chosen strategy of 
performing miRNA profiling in this study, has proven to be a reliable method to 
identify miRNA candidates which are differentially expressed in a state of interest. 
However, this method can not predict if a differentially expressed miRNA is of 
functional relevance in this state. Hence, functional studies and target identification 
has to be performed to assert that distinct miRNA actually contributes to the present 
conditions. Another technical aspect in this study is the array design, which was build 
on the miRBase 8.1 and contained only 250 of the 672 miRNA in the present 
miRBase 13.0, therefore some miRNAs might be missing. RT-qPCR was used to 
validate observations determined by microarray profiling of miRNA expression. The 
successful outcome of qPCR analysis depends upon a number of interconnected 
steps that require individual optimization. To perform qPCR that provides meaningful 
and reproducible results, several parameters, such as RNA extraction, RNA integrity 
control, cDNA synthesis, primer design, amplicon detection, and data normalization 
must be taken into account. The reliability of miRNA expression profiling depends 
also to the quality of the total RNA used as input material. The methodical strategy to 
study the function of the overexpressed and knocked down miRNAs during 
osteogenic differentiation included the analysis of cell morphology, calcium amount, 
ALP activity and verification of osteogenic markers expression. In addition, a 
combined approach of bioinformatic target prediction, mRNA expression analysis and 
TurboGFP reduction upon miRNA overexpression coupled with the search of known 
literature was performed to identify cellular events/pathways the miRNAs might be 
involved in. mRNA expression analysis upon manipulation of miRNA expression 
provides good evidence for which cellular processes miRNAs might modulate. 
However, this method is not applicable to distinguish between primary (mRNAs that 
are targeted by the miRNA directly) or secondary (mRNAs that are differentially 
expressed as a result of activation/inhibition of a signaling pathway/transcription 
factor) effects. To understand how miR-361 interfered with osteogenic differentiation, 
an RNA interference analysis using the p2FP-RNAi vector was performed to identify 
direct targets of the miRNA. The p2FP-RNAi vector makes it possible the trace RNAi 
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in transfected cells by turning off/on green fluorescence against a background of red 
fluorescence. 
 
6.2 miRNAs associated with the stem cell state 
Early development of the embryo is characterized by a very high rate of proliferation 
and differentiation. Starting at the eight-cell stage, the rate of apoptosis increases (El-
Shershaby and Hinchliffe, 1974). In this context, the morphogenesis is due not only 
to the proliferation of cells, but also to the apoptotic elimination of cells. This interplay 
among proliferation, differentiation, and apoptosis is crucial for development.  
Expression profiles of miRNAs in ESCs are different from other tissues thereby 
suggesting their involvement in self-renewal and pluripotency. The crucial roles of the 
miRNAs in both ESCs and early embryogenesis have been revealed in several 
model organisms by loss-of-function genetic analysis of various components of the 
miRNA biogenesis pathway.  In this study miR-183, miR-424, miR-199a, miR-291a-
5p, miR-291b-5p, miR-293, miR-300, miR-466 and miR-467b were the most 
significantly expressed miRNA in undifferentiated ESCs (Fig. 10,). A murine miR-290 
cluster, identified as a region on chromosome 7, was determined to be ESC-specific 
(Houbaviy et al., 2003). The single spliced, capped and poly-adenylated primary 
transcript produced at this locus generates ten mature miRNAs: miR-290, miR-290-
3p, miR-291a-3p, miR-291a-5p, miR-291b-3p, miR-291b-5p, miR-292, miR-293, miR-
294 and miR-295. In consistence with previous findings, in this study, three miRNAs, 
miR-291a-5p, miR-291b-5p and miR-293 were up-regulated in undifferentiated ESCs. 
Expression of miRNA cluster increased during preimplantaion development and 
remained high in undifferentiated ESCs but decreased after ESCs differentiation 
(Houbaviy et al., 2003; 2005). The functional importance of the miR-290 cluster in 
embryogenesis has been demonstrated in a mouse study, in which the generation of 
mutants with a homozygous deletion of the miR-290 cluster resulted in the death of 
the embryos (Ambros et al., 2007). Additionally, there is strong evidence that the 
miR-290 family has a regulatory role in mouse ESC maintenance and differentiation 
(Marson et al., 2008). It has been reported that the key ESC transcription factors, 
such as Oct-4, Sox-2, Nanog, and TCF-3, are associated with promoters for miRNAs 
that are preferentially expressed in ESCs including the miR-290 cluster (Marson et 
al., 2008). Moreover, knockdown of Oct-4 results in decreased expression of the 
miR-290 cluster. As it has been shown in this study, expression levels of miR-291a-
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5p, miR-291b-5p and miR-293 were down-regulated during differentiation. On the 
other hand, the single miRNA can be a regulator of self-renewal in ESCs (Singh et 
al., 2008).  Studies on the transcriptional repressor REST show that by repressing 
the transcription of a specific miRNA, such as miR-21, self-renewal might be 
suppressed with a corresponding loss of expression of the critical self-renewing 
regulators Oct-4, Nanog, Sox-2, and c-Myc. However, whether miR-21 directly 
suppresses the expression of these self-renewing regulators, thereby inhibiting self-
renewal, or whether miR-21 inhibits self-renewal by a different mechanism, with 
consequent suppression of these self-renewal regulators, is unclear. 
The search for general regulators of stem cell self-renewal is fundamental also for 
understanding the regulation of cancer cell proliferation. A normal stem cell and 
cancer cells share the ability to self-renew, thus it seems that newly arising cancer 
cells appropriate the machinery for self-renewing cell division, which is normally 
expressed in stem cells. The finding that let-7 controls self–renewal and 
differentiation in breast cancer stem cells may hint at similar functional roles in ESCs 
(Yu et al., 2007). In addition, evidence shows that many pathways that are classically 
associated with cancer may also regulate normal stem cell development. One 
particularly interesting pathway that has also been shown to regulate both self-
renewal and oncogenesis in different organs is the Wnt signaling pathway (Taipale 
and Beachy, 2001).  
Because murine ESCs are an in vitro copy of an in vivo population of cells known as 
inner cell mass, overexpression of miRNAs might determined the effect of miRNAs 
on cell survival. Here, overexpression of miR-300a, miR-467b and miR-665 had a 
strong impact on ESCs survival compared to control cells, although miR-361 had the 
strongest compared to control cells and other miRNAs (Fig. 14). Therefore, it has 
been suggested that miR-361 could act as a suppressor of cell proliferation. The 
decrease in the activity of MTT reduction, which is considered to reflect the ability of 
oxidative phosphorylation in the mitochondria, was observed. This effect might be 
explained by one of the targets being NFATc-3 (Fig. 26). The NFAT family of 
transcription factors is a key regulator of inducible gene expression. Genes encoding 
the five NFAT proteins are expressed in semirestricted patterns throughout the body. 
NFATc-1, -c2, and -c3 are most highly expressed in immune cells and skeletal 
muscle, as well as weakly expressed in many other cell types. Previously, it has been 
shown that NFAT transcriptional activity is regulated by its interaction with a number 
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of other transcription factors, such as activator protein 1 (AP-1) (Rao et al., 1997), 
myocyte enhancer factor 2 (Mef-2) (Blaeser et al., 2000) and GATA-4 (Molkentin et 
al., 1998), each of which is regulated by additional signaling pathways. In addition, 
MAPKs directly phosphorylate NFAT and modify its activity. Thus, NFAT may 
integrate inputs from multiple signaling pathways and its activation might protect from 
apoptosis (Pu et al., 2003).  
Moreover, Wnt7a, which regulates dedifferentiation of articular chondrocytes and 
inhibits nitric oxide induced apoptosis by activating survival signals (Hwang et al., 
2004) is one of predicted targets of miR-361. Previously, it has been shown that 
apoptosis induced by nitric oxide are regulated by a complicated protein kinase 
signaling cascade, including down-regulation of PI3K and Akt, activation of ERK and 
p38 kinase, and inhibition of PKC (Kim et al., 2002). In this study, we provide the first 
evidence that miR-361 can inhibit cell survival of ECSs. However, other previously 
published data on this miRNA cannot satisfactorily explain the observed effect of 
miR-361. 
 
6.3 miRNA expression in osteogenic differentiation of murine ESCs 
The physiological role of miRNAs especially in the process of differentiation remains 
elusive as only a couple of mammalian miRNAs have been assigned a functional role 
in developmental processes. Understanding the regulatory mechanism of osteoblast 
differentiation is a prerequisite for developing strategies to treat bone loss diseases 
and bone cancer (Rosen et al., 2005; Sambrook et al., 2006; Khosla et al., 2008). 
Progress in molecular and genetic research has uncovered various regulatory 
processes of osteoblast differentiation (Komori et al., 2006; Rosen et al., 2005). 
Central to this regulation are transcriptional factors, such as Runx-2, Osx and CatnB 
which are known to be essential for osteoblast differentiation (Komori et al., 2006). A 
recent study also revealed that miRNAs play an important role in cell function and 
differentiation (Kloosterman et al., 2006; Hobert et al., 2008; Stefani and Slack, 
2008).  
In this study, an initial miRNA profiling in undifferentiated ESCs and differentiated into 
osteoblasts was performed to identify miRNAs, which might be differentially 
expressed in osteogenically induced cells. The tendency that miRNA genes occur in 
clusters is observable during differentiation. Most of the miRNAs showed cluster 
distribution except for some that where expressed alone. On the basis of the 
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microarray data, three miRNA clusters 2, 7, and 12 were found to exhibit decreased 
expression levels after differentiation (Fig. 10, Tab. 6). 
This is, to our knowledge, the first study of miRNA expression profiling during 
osteogenic differentiation of ESCs. 
 
ID Chromosome Start End 
miR-322 X 50407432 50407526 
miR-361 X 110188433 110188502 
let-7e 17 17967316 17967408 
miR-130b 16 17124154 17124235 
miR-690 16 28600021 28600129 
miR-24 13 63402516 63402583 
miR-127 12 110831056 110831125 
miR-300 12 110962523 110962601 
miR-495 12 110956964 110957026 
miR-665 12 110824524 110824617 
miR-22 11 75277218 75277312 
miR-199a 9 21300939 21301008 
miR-711 9 108871967 108872048 
miR-486 8 24253027 24253154 
miR-291a-5p 7 3218920 3219001 
miR-291b-5p 7 3219483 3219561 
miR-293 7 3220344 3220423 
miR-483 7 149840829 149840901 
miR-183 6 30119668 30119737 
miR-466 2 10429545 10429617 
miR-467b 2 10402875 10402947 
 
Table 6. The expression tendency of the miRNAs during spontaneous and osteogenic 
differentiation 
 
6.4 Lineage specific miRNAs that regulate Wnt pathway members 
Multiple miRNAs work in concert to regulate related targets in common pathways. 
Therefore, pathway analysis may provide a better solution to evaluate the biological 
consequences of global miRNA dysregulation. One such important pathway in stem 
cell self-renewal and osteogenic commitment is the canonical Wnt signaling. Though, 
in fact, both the canonical and non-canonical Wnt signaling pathways play a role in 
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development and the complex crosstalk between these two may regulate the cellular 
readout of Wnt signaling (Fig. 32). Specifically, the role of canonical Wnt signaling is 
to regulate cellular function at the level of maintaining the pluripotent state, while both 
the canonical as well as the non-canonical cascade control differentiation (Huelsken 
and Birchmeier, 2001). Moreover, it is a timely-controlled fluctuation between these 
two pathways that steers stem cells down in a specific differentiation path (Davis and 
zur Nieden, 2008). In osteoblastogenesis, the activity of the canonical Wnt upstream 
was observed (Bain et al., 2003; Bodine et al., 2004). The first direct evidence for 
involvement of canonical Wnt signaling in osteoblastogenesis came from the finding 
that loss-of-function mutations in the Lrp5 gene, encoding a co-receptor of canonical 
Wnt signaling (Mao et al., 2001), result in a decrease in bone density associated with 
defects in osteoblast differentiation and proliferation (Gong et al., 2001; Kato et al., 
2002), while Lrp5 gain-of-function mutations are associated with an increase in bone 
mass (Johnson et al., 2004). Furthermore, canonical Wnt signaling is thought to 
support osteogenic differentiation from both precursor lines and stem cell lines in vitro 
(Bain et al., 2003). The first switch in Wnt signaling occurs when ESCs are relieved 
from pluripotency factors, such as LIF or bFGF. Upon differentiation, CatnB uses the 
cofactor E1A binding protein p300 (p300) to regulate the expression of target genes 
in initiating differentiation (Miyabayashi et al., 2007). Thus, the activity level of CatnB 
in the nucleus seems to play an important role. In the nucleus, CatnB binds to the 
transcription factors LEF/TCF triggering downstream gene transcription. Indeed, 
overexpression of canonical Wnt1 in ESCs or stabilized CatnB occurs in the inhibition 
of neuronal differentiation and in the activation of cell cycle genes such as c-myc and 
cyclins supporting self-renewal (Aubert et al., 2002; Haegele et al., 2003). Therefore, 
the regulation of CatnB expression is necessary for differentiation of ESCs into 
mesodermal lineages, such as osteoblasts, adipocytes and chondroctyes.  
It has been reported that miR-200a could function as a regulator during mesoderm 
specification by targeting 3’UTR of CatnB mRNA and inhibiting Wnt signaling. 
Overexpression of miR-200a in human meningioma tumor strongly inhibited the 
response of LEF/TCF-1 promoter to Wnt induction. Thus, this data suggest that miR-
200a can act as a negative regulator of Wnt/CatnB signaling pathway (Saydam et al., 
2009). Based on the other study, it has been demonstrated that miRNA expression 
can be induced by canonical Wnt signaling in osteoblasts. For example, lithium 
chloride (LiCl) treatment which mimics canonical Wnt signaling by inhibiting the 
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activity of GSK-3, resulting in the stabilization of CatnB,  induced miR-29a expression 
(Kapinas et al., 2009; Case et al., 2008). Conversely, treatment of cells with the Wnt 
signaling antagonist Dkk-1 caused an inhibition of miR-29a expression. Thus, 
increased levels of miR-29 mediated by the Wnt signaling, is a vital mechanism 
modulating gene expression during osteoblast differentiation. 
In summary, the Wnt signaling pathway as well as Wnt-regulatory miRNAs is 
therefore undoubtedly important for steering stem cell fate. This study has specifically 
identified two miRNAs, with very promising candidate mRNAs associated with Wnt 
signaling, miR-361 and miR-665. In fact, this study is the first report that 
characterized the detailed molecular basis of osteogenic differentiation controlled by 
miR-361 and miR-665 expression. Both miRNAs shall be discussed in detail in the 
following paragraphs. 
 
Figure 32. Canonical and non-canonical Wnt signaling pathways. There are at least three 
different intracellular Wnt signaling transduction pathways. These are the Wnt/CatnB pathway 
(canonical pathway), the Wnt/Ca2+ pathway and the Wnt/planer cell polarity pathway are combined as 
the non-canonical pathway, which involve the downstream members calmodulin kinase II (CamKII), 
PKC and JNK (Davis and zur Nieden, 2008). 
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6.4.1 miR-361 
Overexpression of miR-361 had the strongest impact on the osteogenic 
differentiation capacity of ESCs (Fig. 16, 17, 19). However, when miR-361 was 
knocked down, the effect on osteogenic differentiation was not evident (Fig. 21-23). A 
possible explanation is that LNA-miR-361 inhibitor binding may not lead to full 
degradation of the miRNA.  Still, the LNA modified inhibitors were chosen because 
they are resistant to cellular ribonucleases and are bound by the complementary 
miRNA in association with RISC. This is a crucial feature to the use of such 
molecules as inhibitors because it provides much greater efficiency than would be 
possible with simple hybridization to the complementary target. Additionally, it allows 
the use of low quantities of the inhibitor, greatly reducing the possibility of off-target 
effects (Hutvágner et al., 2004).  
As the target identification experiments using the p2FP-RNAi reporter showed, miR-
361 is capable of repressing Prickle-1 expression. Among mammals, prickle genes 
have been identified in mouse, and the corresponding proteins are encoded by the 
mouse prickle-like 1 and prickle-like 2 genes (prickle-1 and prickle-2, respectively) 
(Katoh et al., 2003). In mouse, four Prickle orthologues have been identified: Prickle-
1, Prickle-2, Testin and Dyxin (Divecha and Charleston, 1995; Bespalova and 
Burmeister, 2000; Bekman and Henrique, 2002; Katoh and Katoh, 2003). The D. 
melanogaster and Xenopus xenopus prickle proteins and the mouse Prickle-1 have 
conserved three cysteine-rich sequences with a double zinc-finger motif (LIM) 
domain, which is known to play important roles in the fundamental biological 
processes that occur during embryonic stages (Gubb et al., 1999; Tree et al., 2002). 
A recent study exhibited an abundant expression of Prickle-1 in the primitive streak 
and mesoderm during embryonic development (Crompton et al., 2007), implying that 
Prickle is executing some function in early embryogenesis.  
Several investigations suggest that Prickle-1 is capable of regulating Wnt/planar cell 
polarity signaling in D. melanogaster, X. xenopus, and zebrafish through interaction 
with Dishevelled/Dvl, (Drosophila)/(mammalian) (Tree et al., 2002; Takeuchi et al., 
2003; Carreira-Barbosa et al., 2003; Veeman et al., 2003). However, there is no 
information available regarding the involvement of Prickle-1 in bone formation and 
turnover both in the perinatal and mature stages. Listed experiments from D. 
melanogaster, X. xenopus embryogenesis, and mammalian viral oncogenesis, show 
high conservation of components and signaling steps of Wnt canonical pathway 
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among species, and confirm the concept reported elsewhere that the same set of 
signaling pathways are regulating development.  
However, it has been shown that Prickle-1 reduced Dvl-3 levels by promoting its 
ubiquitination, resulting in inhibition of Wnt canonical signaling in liver cancer (Chan 
et al., 2006). Conversely, it has been observed that Prickle-1 underexpression 
correlated with high levels of Dvl-3 and CatnB. Upon stimulation by Wnt ligands Dvls 
inhibit GSK-3 in phosphorylating CatnB and this inhibition stabilizes CatnB in the 
cytoplasm (Kishida et al., 1999; Wharton et al., 2003). Thus, Dvls are positive 
regulators in elevating CatnB level and stimulating LEF/TCF1-dependent 
transcription in the Wnt canonical pathway (Fig. 32) (Li et al., 1999; Hino et al., 2001). 
Thus far, the mechanisms on Dvl degradation have not been clearly reported. 
Analysis of the Prickle-1 sequence revealed the presence of two conserved D-box 
motifs, which are important for ubiquitination-mediated destruction of most anaphase-
promoting- complex targets (Zachariae et al., 1999, Simons et al., 2005). Additionally, 
it has been shown that the depletion of two D-box motifs on Prickle-1 by mutations 
significantly abolished the ubiquitination-mediated degradation of Dvl as well as 
suppression of the CatnB activity. These findings demonstrated that Dvl-3 can be 
degraded via the ubiquitin-proteasome system, while Prickle-1 is a key component 
facilitating the ubiquitination process of Dvl-3. 
 
In summary, miR-361 targets Wnt signaling by interfering with Prickle-1, thus 
implicating that miR-361 is a positive regulator of Wnt signaling and activator in 
osteogenic differentiation of ESCs. This interaction offers a novel mechanism of Wnt 
signaling activation in osteogenesis and can be explored to identify key components 
in Wnt signaling pathway. To the best of my knowledge, this is the first study 
reporting such a relationship between Prickle-1, Wnt signaling and miR-361. 
 
6.4.2 miR-665  
In addition to identifying miR-361 as a potential activator of osteogenesis, the 
presented data indicated that miR-665 is a potential suppressor of osteogenic 
differentiation by interacting with Dvl-1. Knockdown of miR-665 had a strong impact 
on osteogenic differentiation of ESCs, overexpression and knockdown of miR-665 
decreased or increased mineralization, respectively. These effects might be 
explained by the repression of miR-665 on one of its potential targets Dvl-1. Dvl-1 is 
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an essential component of both the canonical and the non-canonical Wnt signaling 
pathways. Upon binding of Wnt molecules to their receptors, either Fzd or a complex 
comprising Fzd and LRP-5/6, a signal is transduced to the cytoplasmic Dvl. The Dvls 
are multifunctional proteins harboring docking sites for more than 20 suspected 
binding partners (Wharton et al., 2003; Wallingford et al 2005). Prominent domains 
found in Dvl, such as DIX, PDZ, and DEP, are highly conserved from the single fly to 
the mammalian Dvl-1, Dvl-2, and Dvl-3. The DEP domain is essential for Wnt/JNK 
cascade activation whereas all domains are necessary for the accumulation of CatnB 
(Boutros et al., 1998). Changes in the cellular levels of Dvl-1 appear to impact the 
canonical Wnt pathway (Lee et al., 2008), as suppression of Dvl-1 attenuated 
signaling in the Wnt canonical pathway while overexpression yielded a greater 
increase in the transcriptional response (Lee et al., 2008).  
The canonical and non-canonical pathways are not definite as some Wnts can signal 
through both pathways (Kuhl et al., 2000), and some downstream targets are 
involved in both, such as Dvl. The combination of pathway members seems to be 
dependent on the cellular context. The commitment of stem cells to osteogenesis is 
coupled with a switch form canonical and non-canonical signaling. Thus, 
enhancement of canonical Wnt signaling is required to maintain the stemness state 
and its abrogation may render the cells to promote osteogenesis (Baksh et al., 2007). 
Furthermore, canonical Wnt signaling mediated by Wnt3a maintains stem cells in a 
proliferative stage while Wnt5a which dose not signal through CatnB stimulate 
osteogenic differentiation. It has been also reported that Wnt5a has the capacity to 
antagonize the canonical pathway by promoting the degradation of CatnB and thus 
down-regulation of target transcripton factors (Topol et al., 2003). Therefore, the 
expression of the non-canonical Wnt5a might be affected by increased levels of miR-
665. The activation of non-canonical Wnt5a has been shown to induce 
osteoblastogenesis through the attenuation of peroxisome proliferator-activated 
receptor γ (PPARγ) - induced adipogenesis in bone marrow mesenchymal stem cells 
(Takada et al., 2007). Wnt5a activated the non-canonical Wnt signaling cascade 
through Ca2+/calmodulin-dependent protein kinase IIa (CaMKIIa) and did not 
activate LEF/TCF-1 canonical signaling (Fig. 32). Furthermore, the same group 
showed that Wnt5a+/− mice had a reduction in bone mass with a reduced number of 
osteoblasts. Taken together, over- or mis-expression of Dvl-1 might influence the 
expression profile of genes involved both in undifferentiated cells and cells 
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differentiated into osteoblasts. Interestingly, miR-665 is located in the same cluster 
with miR-127 in an imprinted locus on mouse chromosome 12 (Tab. 6). Both are 
significantly differentially expressed during osteogenic induction of ESCs. This finding 
is important, since chromosomal location and genomic distribution of a miRNA gene 
are important determinants of its expression from at least three perspectives. First, 
about 80% of miRNA genes are located within introns of defined transcription units 
(Kim et al., 2007), and their expression is frequently correlated with the expression 
profiles of their host genes (Rodriguez et al., 2004; Baskerville et al., 2005). Second, 
many miRNA genes are distributed as clusters and lastly, miRNA genes are 
frequently located at fragile sites, as well as in regions of loss of heterozygosity, 
regions of amplification, or common breakpoint regions (Calin et al., 2004).  
Relatively little is known about miR-127, having 6 Pubmed entries compared to other 
miRNAs, for example 351 publications exist for let-7. Recently, the group Leucci et al. 
demonstrated that human miR-127 may be involved in B-cell differentiation through 
post-transcriptional regulation of X-box binding protein 1 (XBP-1) (Leucci et al., 
2010), confirming at least a role for this miRNA in regulating differentiation. XBP-1 is 
a basic-region leucine zipper protein in the cyclic AMP response element binding 
protein/activating transcription factor (CREB/ATF) family of transcription factors 
involved in different cell-differentiation processes. This protein may, however, not 
only regulate B-cell specific transcription, but was recently revealed to be expressed 
also during osteoblast differentiation of MC3T3-E1 cells. It has also been shown that 
XBP-1 is up-regulated by PTH. Based on the documented anti-apoptotic effect of 
PTH on osteoblasts, the PTH/XBP-1 relationship, and the observed cytoplasmic 
location of XBP-1, may indicate that the anti-apoptotic effect of PTH could in part be 
produced through pathways involving the cytoplasmic activity of XBP-1 (Zambelli et 
al., 2005).  However, to our knowledge there are no publications, which could help to 
elaborate this matter further.  
miR-127 was also reported to be involved in fetal lung development (Bhaskaran et 
al., 2009). The overexpression of miR-127 in a fetal lung organ culture system 
caused defective lung development characterized by decreased terminal bud counts 
and varied bud sizes. In situ hybridization showed that miR-127 tend to shift from the 
mesenchymal compartment of the developing lung to the epithelial cells, which may 
indicate a role for this miRNA in the cellular reorganization process and differentiation 
of alveolar epithelial cells or mesenchymal to epithelial transition.  
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Additionally, the functional studies on miR-127 so far have identified it as a potential 
tumor suppressor whose expression goes down in cancer cell lines and in a 
significant number of primary tumors (Saito et al., 2006). With treatment with 
chromatin-modifying drugs miR-127 expression was up-regulated, and this, in turn, 
inhibited the expression of its target, the protooncogene B-cell lymphoma protein 6 
(BCL-6).  
 
In summary, we would like to suggest the possible connection between miR-665 and 
Wnt signaling which leads to strong inhibition of Dvl-1 after miR-665 overexpression. 
Thus, the loss of miR-665 implicating that miR-665 activates Wnt signaling and 
osteogenic capacity of ESCs. This is the first report which shows such a relationship 
between Dvl-1 and miR-665. 
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7 Conclusions 
In the current study, the microarray data indicated that there were twenty five of 
nearly 250 miRNA significantly differentially expressed between undifferentiated and 
differentiated ESCs. Eleven miRNAs, namely miR-22, miR-127, miR-130a, miR-183, 
miR-291b-5p, miR-293, miR-300, miR-361, miR-467b, miR-665 and miR-690 were 
expressed at low levels and the down-regulation of these miRNAs appeared to be 
common in the osteogenically induced ESCs. Validation four of these miRNAs using 
RT-qPCR with the specific stem-loop primers confirmed the expression levels of each 
miRNA. Overexpressing and knocking down these miRNAs caused changes in cell 
survival, cell morphology, and osteogenic differentiation capacity as measured with 
MTT assay, calcium deposition, ALP activity and expression of osteogenic markers. 
Bioinformatic target prediction, mRNA expression analysis and TurboGFP reduction 
upon miRNA overexpression revealed that these miRNAs had many targets known to 
be associated with Wnt signaling. As the Wnt pathway has been shown to be one of 
the major pathways involved in osteogenic differentiation of ESCs (Day et al., 2005; 
Hill et al., 2005; Hu et al., 2005), the current results suggest a role for the identified 
miRNAs in this process. The activation or repression of Wnt signalling by miR-361 
and mir-665 was shown. Their observed different expression in ESCs differentiated 
toward osteoblasts compared to undifferentiated ESCs suggests a contribution of 
these two miRNAs in the modulation of Wnt signalling. Enhanced osteogenic 
differentiation likely occurs via observed down-regulation of Prickle-1. On the other 
hand, the opposite effect appears through up-regulation of Dvl-1. As Wnt canonical 
signaling controls both cell survival and osteogenic differentiation in ESCs, the latter 
may explain also the observed effect of miR-361 expression on cellular viability and 
mineralization. This complex network of interactions between these two miRNAs from 
different genomic loci and different facets of the Wnt pathway may open a 
perspective for a more system-oriented research on the role of miRNAs and their 
targets in osteogenesis. 
Taken together, we suggest that miR-361 acts as an osteogenic activator and miR-
665 as an osteogenic suppressor, which may have therapeutic implications in 
particular for degenerative bone disorders. The therapies currently used to treat 
these types of diseases are based on the use of pharmacological agents, auto- or 
allotransplants and synthetic materials. However, such modalities can ameliorate 
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symptoms but are not able to cure. Therefore, interference with the Wnt signaling 
pathway would be a conclusive approach. The data of this study may be of 
significance for bone disorder therapies as a strong interference with Wnt signaling 
could be shown.  
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9 Appendix 
9.1 Supplementary tables of miRNA expression 
Microarray data shown that as the differentiation progressed, the number of miRNAs 
with lower expression increased. For all time points the logFC intensity of the majority 
of miRNAs was in the -1 to 0 and 0 to 1 ranges, however, a the time course 
progressed there was an increasing number of miRNAs with log FC expression levels 
>1 and >-1. At an adjusted p-value of q<10-2 (linear model fit for each miRNA with 
moderated t- statistics), 25 miRNAs that were significantly differentially expressed 
(p<0.05) between undifferentiated and differentiated cells during 8 days of 
spontaneous and osteogenic differentiation were identified (Tab.1-6). Of particular 
interest were 11 miRNAs that had a tendency to be down-regulated within the first 8 
days of differentiation in comparison with the undifferentiated ESCs. As can be seen 
in the heat map (Fig.10), the major number of highly expressed miRNAs was 
apparent in undifferentiating ESCs. Although various kinds of miRNAs participated in 
this process, the most dramatic changes were observed in the miRNAs whose 
expression was reduced, which indicated that they were probably the key regulators 
in maintaining the multipotentiality of ESCs. 
 
miRNA logFC AveExpr t p-value q-value B 
miR-486 -0.83 8.54 -6.51 1.10E-06 5.15E-05 5.63 
miR-22 1.82 11.14 6.32 1.73E-06 6.81E-05 5.19 
miR-495 0.79 8.54 6.17 2.46E-06 9.21E-05 4.85 
miR-466 1.66 9.62 6.03 3.51E-06 1.16E-04 4.50 
miR-291a-5p 1.83 10.78 5.97 3.98E-06 1.20E-04 4.37 
miR-361 1.59 10.83 5.78 6.39E-06 1.60E-04 3.92 
miR-291b-5p 1.76 9.96 5.58 1.05E-05 2.46E-04 3.43 
miR-293 1.88 13.15 5.26 2.33E-05 4.17E-04 2.66 
miR-665 1.57 9.83 5.21 2.59E-05 4.52E-04 2.55 
miR-130b 1.47 10.94 5.12 3.28E-05 5.59E-04 2.33 
miR-183 1.32 9.12 4.71 9.27E-05 1.18E-03 1.32 
miR-300 1.08 9.26 4.60 1.21E-04 1.35E-03 1.06 
miR-467b 1.54 9.47 4.34 2.31E-04 2.06E-03 0.43 
miR-127 1.76 10.25 4.15 3.72E-04 2.88E-03 -0.03 
miR-690 1.31 15.03 3.95 6.17E-04 4.30E-03 -0.51 
miR-696 -1.18 8.89 -3.88 7.37E-04 4.89E-03 -0.68 
miR-712 -0.86 10.73 -3.60 1.49E-03 8.80E-03 -1.36 
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miR-483 -1.63 10.10 -3.38 2.51E-03 1.26E-02 -1.85 
miR-711 -0.53 9.74 -3.24 3.52E-03 1.65E-02 -2.17 
miR-130a 1.13 10.50 3.00 6.37E-03 2.65E-02 -2.73 
miR-24 0.49 10.35 2.05 5.19E-02 1.45E-01 -4.63 
miR-199a 0.28 8.40 2.01 5.60E-02 1.52E-01 -4.70 
let-7e -0.07 8.33 -0.72 4.80E-01 6.63E-01 -6.35 
miR-322 -0.10 8.29 -0.62 5.39E-01 6.92E-01 -6.41 
miR-424 -0.01 8.18 -0.06 9.56E-01 9.80E-01 -6.60 
 
Table 1: miRNA expression in differentiated (day 3) versus undifferentiated ESCs. miRNAs most 
significantly differentially expressed between undifferentiated and differentiated ESCs (p<0.05). 
Column headings miRNA, logFC, AveExpr, t, p-value, q-value and B indicate miRNA identifier, the 
log2 of the observed fold change, the average expression, the t-statistics, the p-value, the adjusted p-
value according to Benjamini and Hochberg (Benjamini and Hochberg, 1995) and a log odds score for 
being differently expressed. 
 
miRNA logFC AveExpr t p-value q-value B 
miR-466 1.72 9.62 6.24 2.09E-06 2.61E-04 5.03 
miR-495 0.71 8.54 5.52 1.21E-05 8.25E-04 3.36 
miR-291b-5p 1.70 9.96 5.40 1.62E-05 1.01E-03 3.08 
miR-712 -1.16 10.73 -4.84 6.69E-05 2.79E-03 1.72 
miR-291a-5p 1.46 10.78 4.77 7.97E-05 2.99E-03 1.56 
miR-22 1.27 11.14 4.43 1.87E-04 4.84E-03 0.74 
miR-183 1.24 9.12 4.40 1.98E-04 4.95E-03 0.69 
miR-467b 1.51 9.47 4.24 2.99E-04 6.07E-03 0.30 
miR-293 1.41 13.15 3.95 6.26E-04 1.07E-02 -0.41 
miR-483 -1.71 10.10 -3.55 1.65E-03 2.25E-02 -1.32 
miR-486 -0.42 8.54 -3.32 2.93E-03 3.18E-02 -1.86 
miR-711 -0.54 9.74 -3.30 3.05E-03 3.22E-02 -1.89 
miR-665 0.94 9.83 3.13 4.68E-03 4.33E-02 -2.29 
miR-300 0.72 9.26 3.07 5.32E-03 4.55E-02 -2.41 
miR-361 0.70 10.83 2.55 1.79E-02 1.03E-01 -3.52 
miR-199a 0.34 8.40 2.50 1.98E-02 1.09E-01 -3.61 
miR-130a 0.85 10.50 2.25 3.42E-02 1.54E-01 -4.10 
miR-127 0.88 10.25 2.08 4.91E-02 1.94E-01 -4.42 
miR-24 0.49 10.35 2.07 4.93E-02 1.94E-01 -4.42 
miR-322 -0.32 8.29 -1.93 6.52E-02 2.32E-01 -4.66 
miR-696 -0.55 8.89 -1.80 8.50E-02 2.79E-01 -4.88 
miR-130b 0.46 10.94 1.60 1.23E-01 3.41E-01 -5.19 
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let-7e -0.08 8.33 -0.78 4.46E-01 7.01E-01 -6.12 
miR-690 0.19 15.03 0.57 5.74E-01 7.98E-01 -6.26 
miR-424 -0.09 8.18 -0.37 7.14E-01 8.74E-01 -6.35 
 
Table 2: miRNA expression in differentiated (day 5) versus undifferentiated ESCs. miRNAs most 
significantly differentially expressed between undifferentiated and differentiated ESCs (p-value<0.05). 
Column headings miRNA, logFC, AveExpr, t, p-value, q-value and B indicate miRNA identifier, the 
log2 of the observed fold change, the average expression, the t-statistics, the p-value, the adjusted p-
value according to Benjamini and Hochberg and a log odds score for being differently expressed. 
 
miRNA logFC AveExpr t p-value q-value B 
miR-495 0.82 8.54 6.39 1.45E-06 2.47E-04 5.37 
miR-483 -2.13 10.10 -4.43 1.84E-04 4.45E-03 0.70 
miR-711 -0.71 9.74 -4.35 2.25E-04 5.28E-03 0.50 
miR-183 1.22 9.12 4.34 2.35E-04 5.35E-03 0.46 
miR-300 1.00 9.26 4.27 2.76E-04 5.81E-03 0.31 
miR-466 1.08 9.62 3.92 6.60E-04 1.05E-02 -0.52 
miR-486 -0.45 8.54 -3.54 1.72E-03 2.12E-02 -1.44 
miR-665 0.93 9.83 3.08 5.21E-03 4.83E-02 -2.48 
miR-127 1.22 10.25 2.88 8.32E-03 7.09E-02 -2.91 
miR-291b-5p 0.88 9.96 2.78 1.05E-02 8.62E-02 -3.12 
miR-696 0.72 8.89 2.35 2.77E-02 1.66E-01 -4.01 
miR-712 -0.51 10.73 -2.13 4.40E-02 2.34E-01 -4.42 
miR-199a 0.27 8.40 2.00 5.67E-02 2.78E-01 -4.64 
miR-22 -0.48 11.14 -1.65 1.11E-01 4.46E-01 -5.21 
miR-322 -0.27 8.29 -1.65 1.12E-01 4.48E-01 -5.22 
miR-293 0.53 13.15 1.49 1.50E-01 5.09E-01 -5.45 
miR-130b 0.42 10.94 1.45 1.60E-01 5.32E-01 -5.50 
miR-424 -0.33 8.18 -1.41 1.72E-01 5.54E-01 -5.56 
let-7e -0.14 8.33 -1.34 1.93E-01 5.72E-01 -5.65 
miR-291a-5p 0.37 10.78 1.21 2.37E-01 6.22E-01 -5.80 
miR-24 0.26 10.35 1.08 2.93E-01 6.78E-01 -5.95 
miR-467b -0.38 9.47 -1.06 3.02E-01 6.84E-01 -5.97 
miR-130a -0.17 10.50 -0.45 6.58E-01 9.15E-01 -6.43 
miR-690 -0.09 15.03 -0.28 7.82E-01 9.59E-01 -6.49 
miR-361 0.06 10.83 0.21 8.34E-01 9.65E-01 -6.51 
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Table 3: miRNA expression in differentiated (day 6 of spontaneous differentiation) versus 
undifferentiated ESCs. miRNAs most significantly differentially expressed between undifferentiated 
and differentiated ESCs (p-value<0.05).  Column headings miRNA, logFC, AveExpr, t, p-value, q-
value and B indicate miRNA identifier, the log2 of the observed fold change, the average expression, 
the t-statistics, the p-value, the adjusted p-value according to Benjamini and Hochberg and a log odds 
score for being differently expressed. 
 
miRNA logFC AveExpr t p-value q-value B 
miR-495 0.96 8.54 7.45 1.25E-07 3.96E-05 7.72 
miR-711 -0.80 9.74 -4.89 5.79E-05 2.55E-03 1.82 
miR-466 1.16 9.62 4.22 3.11E-04 7.08E-03 0.20 
miR-183 1.17 9.12 4.18 3.48E-04 7.25E-03 0.10 
miR-483 -1.88 10.10 -3.91 6.77E-04 1.24E-02 -0.54 
miR-486 -0.42 8.54 -3.27 3.33E-03 4.03E-02 -2.05 
miR-300 0.76 9.26 3.25 3.44E-03 4.09E-02 -2.08 
let-7e -0.28 8.33 -2.73 1.19E-02 9.07E-02 -3.23 
miR-712 -0.65 10.73 -2.70 1.27E-02 9.54E-02 -3.29 
miR-665 0.81 9.83 2.69 1.29E-02 9.58E-02 -3.31 
miR-130b 0.64 10.94 2.24 3.47E-02 1.76E-01 -4.20 
miR-127 0.94 10.25 2.22 3.61E-02 1.79E-01 -4.23 
miR-199a 0.29 8.40 2.15 4.21E-02 1.96E-01 -4.37 
miR-22 -0.47 11.14 -1.63 1.16E-01 4.00E-01 -5.23 
miR-696 0.43 8.89 1.42 1.70E-01 4.67E-01 -5.53 
miR-293 0.48 13.15 1.34 1.92E-01 4.93E-01 -5.63 
miR-322 -0.21 8.29 -1.31 2.03E-01 4.95E-01 -5.67 
miR-424 -0.28 8.18 -1.23 2.32E-01 5.39E-01 -5.77 
miR-291a-5p 0.27 10.78 0.89 3.81E-01 6.83E-01 -6.12 
|miR-291b-5p 0.25 9.96 0.79 4.40E-01 7.31E-01 -6.20 
miR-130a 0.24 10.50 0.64 5.26E-01 7.83E-01 -6.31 
miR-361 0.11 10.83 0.39 6.98E-01 8.99E-01 -6.44 
miR-467b 0.12 9.47 0.35 7.29E-01 8.99E-01 -6.45 
miR-24 0.05 10.35 0.21 8.39E-01 9.46E-01 -6.49 
miR-690 0.02 15.03 0.07 9.46E-01 9.87E-01 -6.51 
 
Table 4: miRNA expression in differentiated (day 6 of VD3, AA and β-GP treatment) versus 
undifferentiated ESCs. miRNAs most significantly differentially expressed between undifferentiated 
and differentiated ESCs (p-value<0.05).  Column headings miRNA, logFC, AveExpr, t, p-value, q-
value and B indicate miRNA identifier, the log2 of the observed fold change, the average expression, 
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the t-statistics, the p-value, the adjusted p-value according to Benjamini and Hochberg and a log odds 
score for being differently expressed. 
 
miRNA logFC AveExpr t p-value q-value B 
let-7e -1.10 8.33 -10.90 1.16E-10 8.74E-08 14.43 
miR-22 -2.32 11.14 -8.07 3.21E-08 8.02E-06 9.05 
miR-322 -1.11 8.29 -6.81 5.43E-07 5.09E-05 6.30 
miR-291a-5p 1.88 10.78 6.13 2.76E-06 2.07E-04 4.71 
miR-291b-5p 1.73 9.96 5.48 1.33E-05 7.12E-04 3.17 
miR-424 -1.10 8.18 -4.75 8.34E-05 3.13E-03 1.38 
miR-24 -1.01 10.35 -4.27 2.77E-04 8.00E-03 0.22 
miR-467b 1.08 9.47 3.04 5.74E-03 8.12E-02 -2.68 
miR-466 0.68 9.62 2.46 2.15E-02 1.83E-01 -3.90 
miR-130b 0.66 10.94 2.28 3.18E-02 2.23E-01 -4.25 
miR-183 0.64 9.12 2.27 3.27E-02 2.27E-01 -4.28 
miR-696 -0.61 8.89 -1.98 5.90E-02 2.99E-01 -4.80 
miR-127 0.76 10.25 1.79 8.70E-02 3.33E-01 -5.13 
miR-712 0.38 10.73 1.58 1.27E-01 4.02E-01 -5.44 
miR-665 0.42 9.83 1.39 1.78E-01 4.70E-01 -5.71 
miR-486 -0.17 8.54 -1.37 1.83E-01 4.74E-01 -5.73 
miR-293 0.40 13.15 1.13 2.70E-01 5.77E-01 -6.03 
miR-711 -0.18 9.74 -1.12 2.74E-01 5.78E-01 -6.04 
miR-361 0.27 10.83 0.98 3.38E-01 6.28E-01 -6.18 
miR-495 0.11 8.54 0.87 3.96E-01 6.78E-01 -6.29 
miR-300 -0.20 9.26 -0.85 4.02E-01 6.85E-01 -6.30 
miR-483 0.22 10.10 0.47 6.46E-01 8.47E-01 -6.55 
miR-199a -0.06 8.40 -0.44 6.62E-01 8.50E-01 -6.56 
miR-690 -0.04 15.03 -0.11 9.10E-01 9.73E-01 -6.66 
miR-130a 0.00 10.50 0.01 9.90E-01 9.98E-01 -6.66 
 
Table 5: miRNA expression in differentiated (day 8 of spontaneous differentiation) versus 
undifferentiated ESCs. miRNAs most significantly differentially expressed between undifferentiated 
and differentiated ESCs (p-value<0.05). Column headings miRNA, logFC, AveExpr, t, p-value, q-
value and B indicate miRNA identifier, the log2 of the observed fold change, the average expression, 
the t-statistics, the p-value, the adjusted p-value according to Benjamini and Hochberg and a log odds 
score for being differently expressed. 
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miRNA logFC AveExpr t p-value q-value B 
let-7e -1.22 8.33 -12.05 1.57E-11 1.18E-08 16.32 
miR-22 -2.27 11.14 -7.89 4.73E-08 8.87E-06 8.67 
miR-322 -1.12 8.29 -6.87 4.74E-07 4.76E-05 6.43 
miR-291a-5p 1.72 10.78 5.60 1.00E-05 5.37E-04 3.44 
miR-291b-5p 1.71 9.96 5.43 1.53E-05 7.65E-04 3.03 
miR-199a -0.70 8.40 -5.13 3.21E-05 1.42E-03 2.30 
miR-424 -1.05 8.18 -4.52 1.48E-04 5.28E-03 0.82 
miR-24 -0.81 10.35 -3.40 2.40E-03 4.08E-02 -1.87 
miR-467b 1.14 9.47 3.20 3.96E-03 5.71E-02 -2.34 
miR-696 -0.71 8.89 -2.32 2.92E-02 1.89E-01 -4.19 
miR-711 -0.33 9.74 -2.03 5.44E-02 2.82E-01 -4.74 
miR-183 0.55 9.12 1.95 6.38E-02 3.01E-01 -4.88 
|miR-486 -0.24 8.54 -1.87 7.43E-02 3.18E-01 -5.01 
miR-665 0.54 9.83 1.80 8.51E-02 3.47E-01 -5.13 
miR-466 0.43 9.62 1.55 1.34E-01 4.43E-01 -5.50 
miR-127 0.50 10.25 1.19 2.47E-01 5.54E-01 -5.98 
miR-130b 0.33 10.94 1.14 2.65E-01 5.78E-01 -6.03 
miR-293 0.36 13.15 1.00 3.28E-01 6.38E-01 -6.18 
miR-712 0.16 10.73 0.66 5.16E-01 7.87E-01 -6.46 
miR-495 0.07 8.54 0.53 6.02E-01 8.38E-01 -6.54 
miR-483 0.24 10.10 0.49 6.27E-01 8.49E-01 -6.56 
miR-130a -0.17 10.50 -0.44 6.64E-01 8.67E-01 -6.58 
miR-361 0.09 10.83 0.34 7.34E-01 8.99E-01 -6.62 
miR-690 -0.06 15.03 -0.17 8.65E-01 9.49E-01 -6.67 
miR-300 0.02 9.26 0.10 9.23E-01 9.73E-01 -6.68 
 
Table 6: miRNA expression in differentiated (day 8 of VD3, AA and β-GP treatment) versus 
undifferentiated ESCs. miRNAs most significantly differentially expressed between undifferentiated 
and differentiated ESCs (p-value<0.05).  Column headings miRNA, logFC, AveExpr, t, p-value, q-
value and B indicate miRNA identifier, the log2 of the observed fold change, the average expression, 
the t-statistics, the p-value, the adjusted p-value according to Benjamini and Hochberg and a log odds 
score for being differently expressed. 
 
9.2 Abbreviations 
AA  ascorbic acid 
ALP  alkaline phosphatase 
AP-1  activator protein 1 
APC  axin/adenomotous polyposis coli 
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ATF  activating transcription factor 
BCL-6  B-cell lymphoma protein 6 
bFGF  basic FGF 
BIO  GSK-3 inhibitor 6-bromoindirubin-3’-oxime 
BMP  bone morphogenetic protein 
BSA   bovine serum albumin 
BSP  bone sialoprotein 
CaKM II Ca2+/calmodulin-dependent protein kinase  
CatnB  β-catinin 
Cbfα-1  core-binding factor α1 
cDNA  copy DNA 
Col  collagen 
CREB  cyclic AMP response element binding protein  
ddH2O  double-distillated water 
DEPC  diethylpyrocarbonate 
Dex  dexamethasone 
Dkk-1  Dikkoppf-1 
DMEM  Dulbecco's Modified Eagle Medium 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid  
dNTP  deoxyribonucleotide triphosphate 
dsRBD  dsRNA-binding domain 
dsRNA double-strand RNA 
DTT  dithiothreitol  
Dvl  Dishevelled  
Dxl-5  Distal-less homeobox 5  
E.coli   Escherichia coli 
EB  embroyoid body 
ECM  extracellular matrix 
EDTA   ethylenediaminetetraacetic acid 
ERK  extracellular signal-regulated kinase 
ESC  embryonic stem cell 
ESG-1  embryonal stem cell-specific gene 1 
EtOH  ethanol 
FACS  fluorescence-activated cell sorting 
FC  fold-change 
FCS  fetal calf serum 
9 Appendix 112 
FGF  fibroblast growth factor 
FoxD-3 forkhead box D3 
FoxO-3 forkhead box O3 
fwd   forward 
Fzd  Frizzled 
GAPDH glyceraldehyde-3 phosphate dehydrogenase 
GFP  green fluorescent protein 
GSK  glycogen synthase kinase  
HCl  hydrochloric acid 
ICM  inner cell mass 
Id  inhibitor of DNA binding 
IGF   insulin-like growth factor 
IL  interleukin 
iPSC  induced pluripotent stem cell 
JAK  Janus kinase, non-receptor cytoplasmic protein tyrosine kinase 
JNK  c-Jun N-terminal kinase 
JRed  red fluorescent protein 
LB  Luria-Bertani medium 
LEF  lymphoid enhancer factor  
LiCl  litum chloride 
LIF  leukemia inhibitory factor 
LIM  double zinc-finger motif 
LNA   locked nucleic acid 
LRP-5/6 lipoprotein receptor related protein 5/6 
MAPK   mitogen activated protein kinase 
MCS  multiple cloning site 
M-CSF macrophage colony-stimulating factor 
Mef-2  myocyte enhancer factor 2 
microRNA  micro ribonnucleic acid 
miR   microRNA 
miRISC  miRNA-induced silencing complex 
miRNA microRNA 
mRNA  messenger RNA 
MTT  3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide  
NCP  non-collagens glycoprotein and proteoglycans 
ncRNA non-coding RNA 
NEAA  non-essential amino acids 
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NF-68  neurofilament protein 68 
NFATc  nuclear factor of activated T cells  
nt  nucleotide 
OCN  osteocalcin 
Oct-4  octomer binding protein 4 
OD  optical density  
ON  osteonectin 
OPN  osteopontin 
Osx  osterix 
p300  cofactor E1A binding protein p300 
p38 MAPK P38 mitogen-activated protein kinase 
p53  tumor protein 53 
p75  p75 neurotrophin receptor 
P-bodies precursory bodies 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PG  proteoglycans 
PI3K  phosphatidylinositol 3-kinase 
PITX-2  paired-like homeodomain transcription factor 2  
PKC   protein kinase C 
Pol II  polymerase II 
PPAR  peroxisome proliferator-activated receptor 
pre-miRNA precursor miRNA 
pri-miRNA  primary miRNA  
PTH  parathyroid hormone 
qPCR   quantitative PCR 
RA  retinoic acid 
RANK  receptor activator of nuclear factor κ B-cells 
RANKL RANK ligand 
REST  RE-1 silencing transcription factor 
rev   reverse 
RhoA  Ras homolog gene family, member A 
RIN  RNA integrity number  
RIPA  radio-immunoprecipitation assay buffer  
RISC   RNA induced silencing complex 
RNA   ribonucleic acid 
RNAi   RNA interference 
9 Appendix 114 
RNAPII RNA Polymerase II 
RNase  ribonuclease 
rpm   round per minute 
RT   reverse transcription 
RT-qPCR  reverse transcription quantitative PCR 
Runx-2 Runt-related factor 2 
SAP  shrimp alkaline phosphatase 
scr   srambled 
SDS  sodium dodecyl sulfate 
SFRP-4 secreted frizzled-related protein 4 
siRNA   small interfering RNA 
SMAD  Sma and Mad related proteins 
snoRNA  small nucleolar RNA 
snRNA  small nuclear RNA 
SOX-2  SRY (sex determining region Y)-box 4 
SSEA-1 stage-specific embryonic antigen 1 
SSPE  saline-sodium phosphate-EDTA buffer 
SSPET SSPE, Tween buffer 
STAT   signal transducer and activator of transcription  
TAE  Tris base, acetic acid, EDTA buffer  
T-Bra  T-Brachyury 
TCF  T cell factor 
TE  Tris base, EDTA buffer solution 
TGFβ  transforming growth factor β 
Tris  2-Amino-2-hydroxymethyl-propane-1,3-diol 
UTR   untranslated region 
UV  ultraviolet  
VD3  1α,25-OH2 vitamin D3 
WIF-1  Wnt inhibitor factor 1 
Wnt  wingless 
XBP-1  X-box binding protein 1 
βGP  β-glycerophosphate 
5T4  oncofetal antigen expression 
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